incivo works by stopping the virus from multiplying and infecting people with hepatitis c infection . incivo is used to treat chronic hepatitis c in adult patients ( aged 18 years and older ) who are already taking peginterferon alfa , ribavirin and telaprevir , medicines known as ns3 - 4a protease inhibitors . the ns3 + 4a enzyme is a protein produced by the hepatitis c virus that causes peginerferon ava and ribavir . inciv is used in adult women to treat adult patients who have not previously taken an interferon - based regimen .
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking peginterferon alfa or ribavirin for a long time . if you think this applies to you , tell your doctor . warnings and precautions talk to your doctor before taking incivo . peginerferon avfa or / or ribvirin are not recommended in combination with incivo and should not be taken together with inciv . tell your physician if you take any of , or have recently taken any of any of : the following medicines
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose regimen is three tablets ( 3 mg ) twice a day , taken at the same time each day . the recommended dosing regimen is 3 mg , 6 mg twice a morning , taken 2 mg , 8 mg twice daily , taken in the morning and 6 mg in the evening . if you have both hepatitis c virus infection and human immunodeficiency virus infection , your doctor may prescribe a higher dose of efavirenz . the recommendation dose regimen may be three tablets , 3 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you develop an itchy skin rash . the rash may be serious and needs immediate medical attention . the doctor will treat the rash with other symptoms . the rash may be a severe skin reaction . tell the doctor immediately about a skin rash that you notice . your doctor may treat your rash with another medicine . other symptoms that may be associated with a rash include : fever , tiredness , swelling of the face , swelling or lymph glands , a wide - spread rash , peeling skin , fever , flu - like symptoms ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo produces 375 mg telaprelir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
the active substance of zinbryta is daclizumab beta , a monoclonal antibody . what zinbenta is used for zinbinbryt is used to treat multiple sclerosis ( ms ) in adults . it is used in combination with therapy ( two ms treatment or other treatments ) to reduce inflammation of the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms , which can lead sometimes to repeated attacks ( relapses ). symptoms of ms include difficulty with walking , vision
do not take zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 . if you suffer from liver problems . warnings and precautions talk to your doctor or pharmacist before taking zin bryta . if any of these apply to you , tell your doctor . if your doctor has told you that you have any other autoimmune disorders . if this applies to you ( or you are not sure ), tell your physician . if the dose of any other medicines you take is different from that recommended by your doctor , tell the
your doctor or nurse will give you zinbryta exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much zinburyta is given the usual dose of zinba is 150 mg . your doctor will ask you to have a blood test to check how well your liver is working . the usual starting dose of the first dose of your first dose is one vial of zbrya 40 mg . this blood test will be repeated every three weeks . your dose may be increased or decreased depending on the results of a blood sample . how to inject yourself
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you may need to stop your treatment temporarily or permanently . serious side effects liver problems very common ( may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin and whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may effect up to 1 in 100 people ) severe inflammation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . if you are using a new syringe / pen , it is recommended to use it within a week or two after first opening of a refrigerator . zin bryta syringes / pens may
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml of solution for injection contains 150mg of dlizumb beta . 1ml of solution contains sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zinabryta has sodium '). what zin bryta looks like and contents of the pack zinbaqta is a clear to slightly yellow solution for injecting into a syringe / pen ( pre - used pen
what wilzin is wilzin belongs to a group of medicines called metabolism products . what wilson ' s disease is wilson is due to a rare inherited defect in copper excretion , which affects the liver , eyes and brain . this defect can lead to liver damage and neurological disorders . how wilzin works wilzin attaches to copper in the intestine and causes its further accumulation in the body . this results in wilson s disease . this treatment will benefit you .
do not take wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent , penicillamine . wilzin should be used during the initial treatment in combination with other anti - coating agents , penICillamine may be used if your symptoms do not improve or if the treatment is interrupted . monitoring of blood and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are listed below . the recommended dose is 25 mg or 50 mg once a day . your doctor will tell you how many capsules to take . the dose may be adjusted by your doctor . the usual dose is 1 mg wilzin 50 mg twice a day ( 1 to 2 tablets ) taken once a morning . the doctor will decide how many doses to take each day . the daily dose may also be adjusted if your doctor tells you to take wilzin 25 mg twice daily ( 1 or
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported with wilzin : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ), very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) if wilzin intake causes gastric irritation , treatment may not be fully effective . changes in blood tests may show an increase in some liver and
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do this after the first opening of the blister . donot store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of z zinc acetate dihydrate ). each hard capsules contains 50 mg of the active substances ( equivalent of 167 . 84 mg of of z z zincacetate diydrate ). the other ingredients are magnesium stearate . the capsule shell contains gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( e110 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , oblong shaped , imprinted with " wilzin 50
biktarvy contains the active substance bictegravir . biktarvir is an antiretroviral medicine known as an integrase strand transfer inhibitor . it is also used in combination with emtricitabine , an antirviral medicine ( known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiiretviral medication known as known as called a nucleotide reverse transcriptases inhibitor ( trti ). bikttarvy is used for the treatment of human immunodeficiency virus 1 ( h
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of these , tell your doctor . if you have taken any of any of your following medicines : - rifampicin ( used to treat some bacterial infections such as tuberculosis ) - st . john ' s wort ( hypericum perforatum ) a herbal remedy used to help prevent depression and anxiety . warnings and precautions talk to your doctor or pharmacist before
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may also prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose should be taken in combination with aluminium and magnesium hydroxide mineral supplements , vitamins , magnesium and iron ( see section 2 " biktarvy contains iron "). take these medicines at the same time each day . bikttarvy is also taken with or without food . if you take more biktorvy than you should if
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following : inflammation or infection in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur during hiv treatment . these symptoms may be due to an improvement in the body ' s immune response , enabling the body to fight infections that have no obvious symptoms . autoimmune disorders ( when the immune system attacks healthy body tissue ) are common in patients taking medicines for hiv infections . autoimmune conditions can occur many months after treatment begins .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each bikttarvy tablet contains bic tegravira sodium equivalent to 50 mg bicchegravirin , 200 mg emtracitabin and ten ofovir aluminiumafenate fumarate equivalent to 25 mg tenofovegal . the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide ( e171
novondorm is an oral antidiabetic medicine containing repaglinide , which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body is not able to use the insulin it produces effectively . novonorm is used to treat type 2abetes in adults . treatment is usually started with diet and exercise and weight reduction . your bloodugar may be increased when you start to take novonor or metformin , which are used to control diabetes . noondorm
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonor . if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). if you suffer from a severe liver disease . if your doctor has told you that you are taking gemfibrozil ( a medicine used to lower increased fat levels in the blood ). warnings and precautions 47 if you know that you have liver problems , do not take any more novonors . if any of these apply to you , tell your doctor . if there is a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . you may take no vonorm with food or between meals . however , if you take more novonors than you should if you accidentally take too many tablets , contact your doctor straight away . if possible , take the tablets with a meal or between 30 and 40 mg once daily . if you forget to take no Vonorm if you miss a
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm is hypoglycasemia ( may affect up to 1 in 10 people ). if you have a hypo in section 2 , hypoglycemic reactions are generally mild / moderate . however , hypocemic unconsciousness may lead to coma . allergy allergy ( may occur in up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects include : common ( may effect up
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ) only in 1 mg and iron oxide red ( e 172 ) only for 2 mg tablets . what novonor looks like and contents of the pack novonere tablets are white to off - white , round , flat , bevelled tablets marked
pumarix is a vaccine used to protect adults ( aged 18 years and older ) against pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . pandemicflu is similar to ordinary flu but may be more serious . the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
do not use pumarix if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients of the vaccine ( see section 4 ). these ingredients may be present in trace amounts as follows : egg , chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if this happens , the vaccine may not be fully effective and you may need medical treatment . if you experience an allergic response to any component of pumar
before starting the vaccine , your doctor will tell you : how much pumarix to give you . your doctor may also give you a similar h5n1 as03 . adults ( 18 years of age and older ) pumarax will be given to you by your doctor or nurse . the recommended dose is one vial of vaccine . pumarux is given to children 3 - 9 years of ages and adolescents ( from 3 - 17 years of years of life ). if you have any further questions on the use of this vaccine , ask your doctor , pharmacist or nurse , or nurse at your disposal .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may be life - threatening . if you experience signs of dangerously low blood pressure , shock may be needed . doctors are aware of this possibility and have emergency treatment available . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where the needle is given fever sweating shivering diarrhoea feeling sick uncommon ( may effect up
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the suspension after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after preparation of the vaccine , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 30 . do away with the vial and any remaining suspension . do throw away any medicines via wastewater
what pumarix contains the active substance is split influenza virus ( inactivated ) of the type a ( a / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which is used to treat the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvant contains squalene , dl - α - tocopherol , polysorbate 80 and adjuvants are used to improve the body ' s response to the vaccine . the ingredients are sodium chloride , disodium hydrogen phosphate
somakit t is a radiopharmaceutical product containing the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . it is essentially free of gallium (' 68ga ') edotreaotide . during this procedure , the amount of gallion ( 68g ) edotreeotide is reduced . the solution is then reconstituted in a vein to make it easier for it to be injected into body areas . somakit to is used for a medical imaging procedure called positron emission tomography ( pet scan ). this medical procedure is to obtain images of
do not take somakittoc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking somakttoc if you have had allergic reaction to any ingredient ( listed under section 4 ) of somaknittoc . - if your doctor has kidney or liver problems . - in renal or hepatic disease . children and adolescents do not give this medicine to children and teenagers under 18 years of age because of the risk of dehydration . the examination will be repeated every 28 days . - there are others medical conditions
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . they will keep you informed of their actions and will keep your appointments . the usual dose of somakitontoc is 29 mg / kg . the nuclear medicine doctor supervising the procedure will decide the quantity of somackittoc to be administered . the dose may be adjusted by the nuclear medicines doctor . the maximum recommended dose of a single injection is 200 mg / m2 of megabecquerel . administration of
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakittoc . symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site . the site of the injection may receive low amounts of ionising radiation ( for example , for cancer or hereditary abnormalities ). reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : radiolabelling will be performed by the specialist . somakittoc will be stored at a concentration of 4 to 25 mbq / m2 . do not freeze . storage at the site of administration will be supervised by the nuclear medicine doctor responsible for the storage of radioactive products .
what somakit t contains - the active substance is edotreotide . each vial of powder contains 40 mg of edotereotide . - the other ingredients are 10 - phenanthroline , gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium for radiolabelling . - in the solvent , the solution contains hydrochloric acid . what somakIT t looks like and contents of the pack somakiton t is presented as a white to off - white powder in a glass vial with yellow flip - off cap . the
afinitor is an anticancer medicine containing the active substance erolimus . everolimus slows the growth and spread of cancer cells . afinitor belongs to a group of medicines called hormone receptor - positive advanced breast cancer ( postmenopausal women ) non - steroidal aromatase inhibitors , which are used to keep the disease under control . afinavitor is used in combination with a medicine called exemestane ( a steroid aromase inhibitor ) with hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours ) in the stomach , bowels , lung or pancreas . it is
do not take afinitor if you are undergoing cancer treatment . warnings and precautions talk to your doctor or pharmacist before taking afincer : if you : are allergic to everolimus , sirolimus , temsirolimu or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings , precautions and precautions before taking the first dose of afinit , tell your doctor if you have any problems with your liver . if you suffer from any disease that affects your liver , your doctor may prescribe a different dose of Afin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg of afinitor per day . if you have liver problems , your doctor may prescribe a lower dose of afginitor ( 5 mg per day ) or a higher dose of 5 mg ( 7 . 5 mg ). your doctor will tell you how many tablets to take . if certain side effects occur , your dose may be reduced . your doctor can reduce your dose of the other medicine you take to help control them . your dose will depend on how you respond to
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps . other side effects reported with afincer include : very common ( may affect more than 1 in 10 people ) - increased temperature - chills ( signs of infection ) - fever - coughing - difficulty breathing - wheezing - inflammation of the lung ( pneumonitis 46 common ( might affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from moisture . open the blister and take the tablets out of reach of moisture . do so immediately after taking them . donot use this product if you notice any visible sign of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains the active substance is everolimus . each tablet of afincer 2 . 5 mg contains 2 . 75 mg of everolim . each afininitor 5 mg tablet of prefabricated tablet contains 5 mg of of everlimus . one afinizer 10 mg tablet contains 10 mg of any kind of everbolimus . the other ingredients are butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose , crospovidone , lactos anhydrous . what afinitors looks like and contents of the pack af
what laventair ellipta is the active substance of lavent air ellipta , is umeclidinium bromide and vilanterol . this belongs to a group of medicines called bronchodilators . what laventAir ellipta used for laventear ellipta should be used for chronic obstructive pulmonary disease ( copd ). copd is a long - term condition that causes breathing difficulties . in copd the muscles around the airways tighten . this medicine works by tightening these muscles in the lungs . this helps to open the airway and makes it easier for air to get in and out
do not use laventair ellipta 31 if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : if you have asthma . warnings and precaution talk to the doctor or nurse before using lavent air ellipta : if your asthma is getting worse . if you suffer from heart problems . if your doctor determines that you have high blood pressure . if any of these apply to you , tell your doctor . if the doctor thinks that you may have an eye problem called
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation twice a day . you should use this this medicine for 24 hours at the same time each day . do not use more than your doctor tells you to use . if you use more laventair ellipta than you should if you have used more lavantair elliptas than you have been told to use , contact your doctor immediately . symptoms of using too much lavent air ellipta may include a sudden attack of breathlessness or wheezing . if this attack occurs
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you get any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) and redness rare side effects : ( may effect up to1 in 1 , 000 people ): swelling mainly of the face or mouth ( angioedema ) which may make you feel very wheezy , coughing , having difficulty in breathing , feeling weak or light headed ( collapse or loss of consciousness ) immediate breathing difficulties if you have
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umeklidinia ( equivalent to 65 microgram ) umeleclidium bromeide and 22 microgram s of vilancerol ( as trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose ') and magnesium stearate . what laventear ellipta looks like and contents of the pack laventaire ellipta is an
the active substance of tremfya is guselkumab , a monoclonal antibody . this medicine contains the active substance " il - 23 ", which is a type of protein that is found in the skin and nails . it is used to improve the condition on which most people have psoriasis . moderate to severe " plaque psorism " is an inflammatory condition that affects the skin , especially the nails . tremfYA works by helping improve the shape and appearance of nails . this helps to reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and symptoms talk to the doctor or nurse before using this medicine if you : have ever had an infection or an infection with tuberculosis 36 have ever been in close contact with someone who has an infection . symptoms of an infection are listed below . infections and allergic reactions if you receive a vaccination
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya is 100 micrograms ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ). you may inject tremfia at intervals of up to 4 weeks , up to 8 weeks after your last injection . if you use more tremfyna than you should if you inject more tremfaya than you have been told to , contact your doctor . if possible , show them the pack . if tremfja is not used immediately , you may have to wait
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious ( may affect up to 1 in 10 people ): upper respiratory infections common side effects ( may effect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not give this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre -- filled syringes and allow it to reach room temperature ( up to 30 ) before use . do this medicine once it
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what tremfYA looks like and contents of the pack solution for injection in a vial . tremfia is supplied as a carton pack containing one single - dose glass syringe and a multipack containing 2 ( 2 packs of 1 ) single - set pre -filled syringes .
the active substance of trepulmix is treprostinil . treprosteinil belongs to a group of medicines called prostacyclins , which are made up of hormone that help to control blood pressure by relaxing blood vessels . prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ). persistent or recurrent ctph is characterised by surgical treatment , poor exercise capacity and symptoms of the disease . chronic throembolic pulmonary hypertension ( pth ) is caused by a condition in which blood pressure
do not take trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen and there is a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - warnings and precautions talk to your doctor or pharmacist before taking trepulemix - tell your doctor if your baby has a heart problem . - tell the doctor if he
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is intended for a continuous subcutaneous infusion ( subcutaneously ) under the skin , through a small tube ( cannula ) in the abdomen or thigh . trepanmix is supplied in a pouch or a portable pump . you can use your treprostinil either directly or by pushing the pump through the infusion line . the recommended dose is one dose ( 1 mg ) once a day . the dose may be increased or decreased depending on your condition . the infusion rate may
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the infusion site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in 100 people ): dizziness , light - headedness , fainting low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgia ), swelling of feet , ankles , legs , fluid retention , hot flush pain in arms and / or legs 36 uncommon ( may effect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after reconstitution , trepulmix can be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 30 days at 2 - 8 unless dilution
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg of treproprostine ( as sodium salt ). each 10 ml vial of 10 ml contains 10 mg of Treprostrine ( as water for injections ). - trepulesmix 2 . 5 mg : one vial containing 2 . 25 mg of the active substances are treprosticinil ( asodium salt ). - each 10ml vial with 25 mg treprostail ( is sodium salt ) contains 50 mg of of trepil ( and sodium salt
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). thorinanes is used in adults to : 1 prevent existing blood clots from forming . 2 prevent stopping blood cl clots forming in your blood . thorinne is used to : - treat blood clumps in your bloodstream . - prevent blood clops from forming in the blood after an operation . - treat an acute illness called unstable angina . - protect your heart after a heart attack . - reduce the risk of blood clot forming in a blood vessel when you are on dialysis
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). if you have had a reaction to heperin which resulted in a severe drop in the number of your clotting cells ( platelets ). this reaction is
like other similar medicines ( medicines to prevent blood clotting ), thorinane may cause bleeding . the bleeding should be stopped immediately . if you experience any bleeding event that does not stop immediately , including exceptional weakness , tiredness , paleness , dizziness , headache , or unexplained swelling , stop taking your medicine and contact your doctor immediately . your doctor may decide to temporarily or permanently stop your treatment with thorinANE . if a severe allergic reaction occurs , difficulty breathing , swelling of the lips , mouth , throat or eyes , or blockage of a blood vessel ( a blood clot ) occurs , cramping pain , redness , warmth
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiratory date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice that the thorinane pre - filled syringes are damaged or have not been stored correctly . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . one ml contains 100 mg of enoxapearin sodium ( as monohydrate ). each pre - filled syringe contains 0 . 2 ml of solution for injection , equivalent to 2 , 000 mg of the active substances in each syringe . the other ingredients are enoxafarin sodium and water for injections . what thorinanes looks like and contents of the pack thorinANE is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield , with chlorobutyl rubber stopper and a blue polypropylene plunger
sensstend contains two active substances : lidocaine and prilocaine . both belong to a group of local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men , when the head of the penis is erect ( ejaculation ).
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a history of allergy or sensitivity to local anaesthetics ( amide - type local anaesthesia ). if your doctor has told you that you have or have had a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ), anaemia ( methaemoglobinaemia ). warnings and precautions talk to your doctor or pharmacist before using this medicine if any of these apply to you . if you : have a family
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 3 sprabs per day ). the first dose is 1 spray ( 1 spray ) into the head of your penis . after that , the first 3 sprashes are 24 sprays per day . the second dose is 4 sprays . how to use use the spray container before using the pump mechanism . the valve is closed to avoid contact with eyes , nose , mouth and ears . after using the spray , 1 spray into the foreskin
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with this medicine : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may effect up to1 in 100 people ) headache local irritation of the throat , irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the part of your penis pain or discomfort in the pris itching in the space between the penis and the vagina a high temperature . other side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer after this period . puncture and burn do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilconaine . 50 mg : each spray delivers 7 . 5 mg lidOCaine and 2 . 5mg prilucaine . - each spray container contains 6 . 5 ml of water for injections . 20 mg : the active substance is lidocane . each spraycontainer contains 5 ml or 12 ml of light yellow cutaneous spray . what senstends looks like and contents of the pack the solution is a clear , colourless to light yellowcutaneous spray
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults . adults melanoma can be treated with complete resesection in adults ( treatment with surgery or adjuvant therapy ) advanced non - small cell lung cancer or advanced stage of lung cancer in adults advanced renal cell carcinoma or advanced kidney cancer in adult classical hodgkin lymphoma if previous therapies have not worked or you are unable to receive an autologous stem - cell transplant ( a transplant ). advanced cancer of the head and neck in adultsadvanced urothelial carcinoma ( bladder and urinary tract cancer ) the
do not take opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking opdivol if you : - have problems with your heart , such as a change in the rhythm or the heartbeat , or an abnormal heart rhythm . - have any problems with any of your lungs , such breathing difficulties or cough . - had inflammation of the lungs ( pneumonitis or interstitial lung disease ). - have diarrhoea , watery , loose or soft stools . - experience any symptoms of inflammation
opdivo will be given to you by a doctor or nurse . the recommended dose of opdivo is 240 mg given as 2 injections ( 480 mg ) every 4 weeks . your doctor will prescribe opdivothab in combination with ipilimumab for the treatment of skin cancer . the dose of opsdivo given will be divided into 1 mg / kg nivolumab per kilogram of your body weight every 4 week . the usual dose of ipilimab is based on your weight . the treatment will be split into two parts : opdivos 240 mg taken as 2 separate injections ( 240 mg )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store below 25 and transport refrigerated ( 2 - 8 ). do not freeze . after dilution , chemical and physical in - use stability has been demonstrated for 48 hours at 2 - 5 . from a microbiological point of view , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg or 240 mg of 24 mg of the active substances . the other ingredients are : nivodumab , sodium citrate dihydrate , sodium chloride ( see section 2 " opdivos contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections . what opdiv
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel tetad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel tad : 30 if you are allergic to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you ( or you are in any doubt at all ), consult your doctor before taking clopridogrel tart . warnings and precautions talk to your doctor or pharmacist before taking any of your other conditions
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl tad ( 4 tablets of 75 mg ) once at the start of treatment . then
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopidiogrel tetad looks like and contents
tacforius contains the active substance tacrolimus . tacforius is an immunosuppressant . after your organ transplant ( liver or kidney ), your body ' s immune system will try to reject the new organ . tacfortius will help to prevent rejection of the transplanted organ by your body , and will help you to regain your health and life style . tacfius will also help to reduce the risk of rejection of transplanted organs by your liver , kidney and heart . it will also reduce the need for any previous treatment you were taking after your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , to any macrolide ( antibiotic ), erythromycin , clarithromycin or josamycin . warnings and precautions tacforus immediate release capsules ( e . g . tacni ) are not available . tacforian prolonged - release capsules are not recommended for patients who are unable to swallow tacrolamus . tac forius prolonged -release capsules are available in two strengths : tacrolem
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . patients who are already taking the same tacrolimus medicine before transplant will be given a different tacroleus medicine . always take this medication exactly as described in this leaflet . check your doctor if you think this medicine is not the right medicine for you . the dose you will receive will depend on the severity of the rejection caused by your transplanted organ . the usual starting dose for adults and children for children of
like all medicines , this medicine can cause side effects , although not everybody gets them . infections you will be closely monitored for infections during treatment with tacforius and you may experience severe effects , including allergic and anaphylactic reactions , benign and malignant tumours . in some cases , tacforia treatment may be stopped completely . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis ( a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ), febrile neutrop
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). discard all the prolonged - release hard capsules within 1 month of opening the aluminium wrapping . do away with the foil . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforus 0 . 5 mg : each capsule contains 0 . 25 mg of tacrolamus ( as monohydrate ). tacforian 1 mg : one capsule contains 1 mg of of tacrulimus ( monohydrate ) . tacofius 3 mg : three capsules contain 3 mg of trimrolimlus ( asmonohydrate ). the active ingredient is tacforous . tacfius 5 mg capsule contains 5 mg of medicine ( monohydrate ). the other ingredients are capsule content hypromellose 2910 , ethylcellulose , lact
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , do not take the next dose of clopridogrelzentiva . warnings and precautions talk to your doctor or pharmacist before taking clopidineogrel xentiva if any combination of the following applies to you
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expletiry date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep clopidogrel zentiva in aluminium blisters in order to protect from light . do away with clopridogrel zinc zentva if it is accidentally frozen . once thawed , it must be used within 30 . do this once thawed . doxorbed on clopidineogrel
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopigrel ( as hydrogen sulphate ). see section 2 ' clopiderel zenta contains lactose ' and ' clapidogl zentive contains hydrogenated castor oil '. the other ingredients are mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e464 ), triacetin
yttriga is a radioactive medicine that is used in combination with another medicine to deliver tiny radiation doses . the treatment is a radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - - if your child is pregnant or breast - feeding . - if the child is able to become pregnant . warnings and precautions talk to your doctor , pharmacist or nurse before using yttrida - yttrada is a radioactive medicine and it must not be used in combination with another medicinal product . - radiopharmaceuticals containing yttra are not to be disposed of via wastewater or household waste . radioactive material is disposed of in radioactive medicinal products . see section
the treatment will be initiated by a doctor experienced in the diagnosis and treatment of medicinal products . method of administration yttriga should be administered under the supervision of a physician experienced in radiolabelling of medicinal product . dosage and frequency of administration the following specific diseases should be considered when deciding upon the dose of yttiga you should receive . in the event of overdose , your doctor will provide appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . the storage details are as follows : keep out of the reach and sight of children . do not use yttrigga after the expiry date which is stated on the label and carton after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25c . store the vial in the original package in order to protect from light . radioactive substances and waste material should be disposed of in accordance with local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). what yttiga looks like and contents of the pack yttrida is a clear , colourless to pale yellow solution in a colourless type i glass vial of 10 ml with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains the active substance cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , which has not received prior chemotherapy . cimbra is also used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will determine how ciamra will be given to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy . your
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciamb . - if your child is less than 6 months old . - before starting breast - feeding , your doctor will decide whether treatment with ciamba is appropriate . - you have recently received a vaccine against yellow fever . warnings and precautions talk to your doctor or nurse before using ciamBra if you have or have had problems with your kidneys . before you receive ciama , your healthcare professional will check your blood and kidney function to make sure that you have enough blood cells and that
the recommended dose of ciambra is 500 micrograms per kilogram of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out your dose based on this body surface area and will adjust the dose and duration of treatment depending on your blood cell counts . your healthcare professional will have mixed the ciamra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before giving you ciamBra . ciamba will be given by infusion into one of your veins . the infusion will last approximately 10 minutes . cimbra
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ) with a temperature of 38ºc or greater sweating ( common ). infection ( uncommon ) with less white blood cells than normal ( very common ). this can be a sign of infection ( sepsis ) which may be severe and could lead to death . if you have chest pain ( common ), with a fast heart rate ( uncommon ). if you get pain , redness , swelling or sores in your mouth ( very rare ). allergic reaction ( common ): skin rash ( common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . do use the reconstituted solution immediately after preparation . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 7 , unless stored at 15 to 25 . the reconfituted product
what ciambra contains the active substance is pemetrexed . each vial of ciamba 100 mg contains 100 mg of pemetreed ( as pemetrifunctional disodium hemipentahydrate ). each vials of cembra 500 mg contains 500 mg of the active ingredient pemetereed (as pemetretrexed disodiumhemipenthydrate ) after reconstitution , the solution contains 25 mg / ml of pemrexed ( see section 2 " ciamra contains sodium "). further dilution by a healthcare professional is required prior to administration .
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) which help protect you against certain infections that are in your blood . immunogam can be used to prevent increased levels of human hepatitis b immunoglubulins , such as immunoglofulin g ( ig ) in blood plasma of screened patients . immunoglogam is used to treat adults and children aged 2 years and above . immunomodialysed patients are not recommended vaccination because immunogamb is a hepatitis b virus carrier . immunogenam works by inhibiting the production of trace amounts of hepatitis b antibodies . vaccination
immunogam must not be given if you have ever had an allergic reaction to human immunoglobulins or other blood products . if you suffer from an iga deficiency , you must tell your doctor immediately if you experience an allergic response to iga containing products . children and adolescents immunogam should not be used in children and teenagers under 18 years of age . immunoglubulins have not been studied in this age group . adverse reactions such as chills , headache , fever and vomiting have been reported . allergic reactions such nausea ( arthralgia ), joint pain , low blood pressure and moderate low back
immunogam will be given to you by a doctor or nurse who is experienced in the care of patients with vaccination against hepatitis b virus . the first vaccine dose will be administered in combination with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose of hepatitis b in individuals who are immunoglodialysis dependent is 500 mg given every 24 hours for 72 weeks . the recommended recommended dose for hepatitis bin haemodialysed patients is 500 μg given every 2 weeks . seroconversion is the first step in vaccination of hepatitis c . immunogam must be administered by a hepatitis b
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported with immunogams : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ). not known ( frequency cannot be estimated from the available data ) if any of the above occurs , please tell your doctor . undesirable effects reported during clinical trials with immunomodulation of the muscle ( injection site ) very common : may affect more than1 user
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do do not take immunogams if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains the active substance is human hepatitis b immunoglobulin . immunogams 1 mg / ml solution for injection contains 5 mg of human plasma protein ( equivalent to 96 mg / m2 ). the other ingredients are polysorbate 80 . what immunogaman looks like and contents of the pack immunogamer is a solution forjection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . it comes in a pack of 1 vial with a desiccant .
remicade contains the active substance infliximab . infliximaab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfα ). remicade belongs to a group of medicines called ' tnfs blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew ' s disease ) psoriasis . remicades is used in adults , adolescents and children aged 6 years and older . these diseases
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to any of these ingredients if you have tuberculosis ( tb ) if your doctor thinks you may have another serious infection , such as pneumonia , sepsis or heart failure if you drink alcohol before taking remicada . if you take remacade if any of this applies to you , tell your doctor before taking the next dose . if any change in your treatment with remicase has occurred in the past , tell
the usual dose for adults with rheumatoid arthritis is 3 mg per kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases is 5 mg per kilogram of bodyweight . how remicade is given remicine is given as an infusion ( drip ) over 2 hours into one of your veins ( usually in your arm ). the third treatment will be given after remicades has been given over 1 week . how much remicad is given your doctor will decide
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects and require treatment . if you experience any of the following side effects during your treatment with remicade , tell your doctor straight away : - an allergic reaction : - swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are usually mild to severe and disappear within a few days . an allergic response is usually mild and usually clears up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . remicade can be given as an infusion for up to 3 days at 2 to 8 , followed by a 28 - day period ( including an additional 24 hours at 25 ) without interruption . do this until the date of removal from the refrigerator . donot use this medication if you notice particles in
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixab . after reconstitution each ml contains 10 mg of infiximabe . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicad is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white and the solvent is clear . remicada is available in packs containing 1 , 2 , 3 , 4 or 5 v
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson's disease ). with parkinson ', s disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body that helps the brain to perform tasks such as movement control . rasagilinea mylan increases the amount of dopamine in your brain .
do not take rasagiline mylan - if you are allergic to rasabiline or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : - rasaline mylan : - monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease - medicinal and natural products such as st . john ' s wort - pethidine , a strong pain killer , used in adolescents rasaga mylan
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . take rasagiline mylan at about the same time each day . you can take razagilide mylan with or without food . if you take more rasgiline than you should contact your doctor immediately . take the rasvagiline melan carton with you so that you can easily describe what you have taken . if possible take rrasagilrine mylan as soon as you remember . if
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of rasagiline mylan are similar to those of placebo . the frequency of possible side effects listed below is defined using the following convention : very common abnormal movements ( dyskinesia ) headache common abdominal pain uncommon rare cases of fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite , constipation , dry mouth , nausea , vomiting flatulence , abnormal results of blood
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasgiline tartrate equivalent to 1 mg rasgailine - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch and talc , stearic acid . what rasaggilinemylan looks like and contents of the pack rasigiline tablets are 11 . 5 mm x 6 mm , white to off - white , biconvex tablets debossed with " r " on one side and "
do not use hulio - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe infection , including tuberculosis . symptoms of infections may include fever , wounds , feeling tired , dental problems . - if the child has moderate or severe heart failure . - tell your doctor if the patient has a serious heart condition . warnings and precautions allergic reaction allergic reactions may include symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . these reactions are usually mild and go away within a few days . infections tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents from 2 to 17 years old weighing 10 kg or more : one 30 mg tablet of hulio 20 mg is available . children and adolescent from 2 - 17 years of age weighing 30 kg or less : one 40 mg tabletof hullio 40 mg is also available . enthesitis - related arthritis in adults from 6 to 17 year old weighing 15 kg or greater : one 20 mg tablet ( tablet ) of hula 20 mg will
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and may not require urgent medical treatment . tell your doctor straight away if you notice any of the following side effects ( which may occur up to 4 months after the last hulio injection ): allergic reaction including heart failure severe rash or hives swollen face , hands or feet , trouble breathing or swallowing pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection include fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired , coughing up blood
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulios looks like and contents of the pack hulIO 40 mg is a sterile solution for injection ( injection ) containing 40 mg of adalimab in 0 . 8 ml of solution . it is clear to slightly opalescent and has a rubber stopper . hullio is available in packs containing 1 , 2 , 1 , 1 sterile injection syringe ,
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which reduce inflammation . yellox has been prescribed for the treatment of eye inflammation in adults undergoing cataract surgery .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed you a lower dose of either : - asthma , skin allergy , intense inflammation in your nose - other nsaids ( such as acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine may be used in combination with topical steroids ( such such as cortisone ) which may increase the risk of unwanted side effects . - bleeding problems ( such a history of haemophilia
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in your eye ( s ) twice a day . the recommended daily dose is two drops in the affected eye (s ) twice daily . for 2 weeks , the drops will be used every day . use in children and adolescents the recommended starting dose is three drops in your affected eye each day . if you use more yellox than you should if you accidentally use too many drops , contact your doctor immediately . method of administration yellox is for oral use .
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromfinac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate , sodium hydroxide ( to maintain acidity levels ). what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass
duzveo contains sufentanil , which belongs to a group of strong painkillers called opioids . suffentenil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzuvoo - tell your doctor if you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuveco may affect your breathing during treatment . - tell the doctor if : - you have a head injury - you suffer from brain tumour - you experience problems with
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for oral use only . swallow the tablet whole with a glass of water . do not chew or crush the tablet . you should swallow the whole tablet with a drink of water , preferably within one hour after taking the tablet , even if it is not completely empty . do this if you feel that the effect of dzuveo is too strong or too weak . if you take strong painkillers such as sufentanil , the usual dose is 30 mg once a
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : - severe breathing problems , especially slow and shallow breathing . if you get any of these side effects contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): - nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may effect up to 1 in every 10 people ) - inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drowsiness , feeling sleepy
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use this product if you notice any visible signs of deterioration . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of sufantanil ( as citrate ). - the other ingredients are mannitol , dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium stearate . what dzuvoo looks like and contents of the pack dzu veo is a white to off - white , round oval tablet with " nvr " on one side and " 3 " on the other side . it is supplied in a
elleada is a cancer medicine containing apalutamide that is used to treat prostate cancer that has spread to other parts of the body and cannot be treated with surgical treatments . it is used in adult men with sensitive prostate cancer which has spread beyond the original body and has not responded to surgical treatment . it reduces the amount of testosterone in the blood and is therefore called " testosterone - resistant prostate cancer ". erleada also reduces the levels of androgens in the body . it also reduces their activity , which can cause the cancer to grow . by reducing the amount androgens , apalotamide stops prostate cancer cells from growing
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may be pregnant . - if if you think you may ( or might become pregnant ) are planning to have a baby . ( see pregnancy and contraception section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine should not be taken with food or drink . this is because this medicine may cause seizures . - tell your doctor if you take any medicines to prevent blood clots ( e . g . warfarin or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how you respond to erleada . take this leaflet with you . this medicine is taken by mouth . do not swallow the tablets . if you take more erleade than you should if you accidentally take too many tablets , contact your doctor immediately . taking other medicines please tell your doctor if you have taken more tablets than you have been told to . if possible , take your tablets with
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you have any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis ( see section 2 ). serious side effects tell your doctor straight away if you notice any of these serious sideeffects . fits ( seizure ) may
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalectamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine cellulosa . - film - coating : iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide . what erlead looks like and contents of the pack
what axumin is axumin contains the active ingredient fluciclovine . it is used for diagnostic use only . it can be used in adults who have not had a scan before ( such as a pet scan ). it is also used in patients who have previously had treatment for prostate cancer and who have had other tests ( prostate specific antigen ( psa ) performed before to find out how the cancer is getting worse . an axumin pet scan is intended to help your doctor determine whether the cancer has responded to the test . the scan will be done under the supervision of a doctor who is experienced in the use of this type of
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . - if your doctor has told you that you have kidney problems . - you should follow a low sodium diet . - axumin is given once a day for the duration of the axumin scan ( see section 4 for further information about the duration and duration of this treatment ). - before the scan , you should take your usual medicines for the latest 60 minutes . - urination during the time following the scan
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in special controlled areas . this medicine will only only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the usual dose is 370 megabecquerel per kilogram of body weight . the administration of axum will be in accordance with official recommendations . the procedure
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( affects more than 1 user in 100 ) the effects of the medicine were mild . common ( effects 1 to 100 users in 1 , 000 ) the following effects were observed : pain , rash , altered taste in the mouth , altered sense of smell . the following serious side effects have been reported with axumin : very rare ( affects less than 1 users in 100 , 000 ): pain , or rash , or altered taste , or a changed sense of taste . the safety and efficacy of
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : axumin will be stored under strictly controlled conditions .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each tablet contains 1600 mg of fluciniclovine ( as mesilate ). - the other ingredients are : 16000 mg : axumin 3200 mg : one tablet contains 3200mg of fluiclovin ( as Mesilate ), 3200 micrograms of 32000 microgram ( as besilate ) - the ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin with sodium "). what axumin looks like and contents of the pack
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops are used to treat high pressure in the eye in adults , adolescents and children with an illness called glaucoma . the pressure in your eye increases , which can damage your sight .
do not take azopt - if you have severe kidney problems - if your doctor thinks you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). - if any of these apply to you , tell your doctor before taking azopt . - if the patient is allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if any part of the following applies to you : - if this applies to your child , tell the doctor immediately .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used in both eyes . use in both eye : 1 drop in the affected eye each time . do not use azopt in both the eyes , either for 1 hour or 2 hours , or for 3 hours . remove the azopt bottle from the bottle and wash your hands . remove from the cap . remove off the cap and snap collar . hold the bottle , pointing down , between your thumb and a finger . tilt your head back . pull down your eyelid with a clean finger until there
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects ( might affect upto 1 in 100 people ) ( effects in and around the eye ): sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to prevent infections , a pack containing a single bottle should be used immediately . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzaolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( to maintain acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ). it is supplied in a pack containing one 5 ml plastic ( droptainer ) bottle with a
the active substance of forxiga , dapagliflozin , belongs to a group of medicines ( medicines ) taken by mouth for diabetes . it helps control the level of sugar in your blood when you are older than 18 years . forxigo is used to treat two types of diabetes : type 1 diabetes that occurs when your body does not produce any insulin . for xiga is used in adults with type 1 , and in people who are overweight or obese . type 2 diabetes : diabetes occurs when the body does less to make enough insulin or where the insulin is not working properly . for this type of diabetes , your blood
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you , tell your doctor straight away . - if your doctor notices that you are feeling sick or being sick , have stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is 10 mg once a day . your doctor may increase your dose to 5 mg once daily if you have a liver problem . your dose of the forxige for type 1 diabetes is 5 mg twice a day , depending on your response to this medicine swallow the tablet whole with a glass of water . forxigo can be taken with or without food . your blood sugar should be checked regularly during treatment with diet and exercise program . if you take more
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( very rare , may affect up to 1 in 10 , 000 people ). angioEDema may cause swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( very common , may affects more than 1 in10 people ) is a complication of type 2 diabetes . it is rare , but may affect 1 in 1 , 000 to 1 , 500 people . diabeticketoacidemia may occur with increased levels of " ketone bodies "
what forxiga contains - the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapablifloin . - the other ingredients are : tablet core : microcrystalline cellulose ( e460 ), lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone , silicon dioxide ( e171 ), magnesium stearate . film - coating : polyvinyl alcohol ( partially hydrolysed ), titanium dioxide ( i171
mifamurtide stops the growth of certain bacteria which may interfere with the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults and children aged 2 and 30 years . it is used when surgery is not possible to remove the tumour and chemotherapy has not worked or has stopped the growth and spread of cancer cells . it also helps to prevent cancer from coming back .
do not take mepact if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). if you take medicines containing ciclosporin or other cineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). nsaids can affect your heart or blood vessels , which may result in blood clots ( thrombosis ), bleeding ( haemorrhage ), or inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking mepactor if any of these apply to you . mep
treatment mepact will be given to you by a doctor or nurse . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of mepACT is 2 mg mifamurtide once a day for 12 weeks . this will be followed by 24 weeks of your mepacts treatments . your doctor will adjust your chemotherapy schedule according to your chemotherapy needs . the maximum dose you receive is 36 mg once a week . how to use treatment mepat is given by infusion ( drip ) into a vein ( intravenously )
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients taking mepacts ( transient ) paracetamol . fever has been reported during treatment with mepACT . stomach problems ( nausea , vomiting and loss of appetite ) have been very common in patients receiving chemotherapy . tell your doctor immediately if you experience continuing fever and chills after 8 weeks of treatment with treatment with mypact . signs of an infection such as rash , tell your physician if you have any problems breathing , wheezing or any stomach problems . very common side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and the outer carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in outer cartons in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 9 ) for up to 6 months . do this medicine if you notice any visible sign of deterioration .
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mifamanurtide ( as besilate ). after reconstitution and suspension , each ml contains 0 . 08 mg mifamate . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 ' mepacts contains sodium '), 2 - dileoyls - sn - glyco - 5 - phospho - l - serine monosodium salt ( see also section 2 " mepACT
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin of the face to reduce redness ( rosacea ) and redness of theface . rosica is caused by high levels of blood flow in the facial skin and enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels , which reduce the excess blood flow and red skin .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). warnings and precautions talk to your doctor or pharmacist before taking mirvasos : - if the medicine is injected under the skin ( for example , if you take certain medicines used to treat depression or parkinson ' s disease ) - if your doctor has prescribed monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , moclobemide ), tricyclic antidepressants ( e. g . imip
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin on the face . this medicine is applied slowly to the surface of your body . it should be applied only on the surface where your body faces the most important areas . avoid placing the application on your eyes , mouth , nose or vagina . do not touch the area where mirvasos is applied . if you use more mirvasoe mirvasoa is applied on the same area of your face every day . the treatment should be continued until you have used a small amount
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects that may be signs of worsening of rosacea are : worsening of the condition of the skin , which may be accompanied by tingles , sensationof pins and toes or swelling ( see section 2 ' warnings and precautions '). contact allergy : allergic reaction including rash and rare angioedema ( a serious allergic reaction with swelling mainly of the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the tube and pumps tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate tartrate . - the other ingredients are carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasos contains methylparasahydrobenzoates "), propylene glyccol . what mirvasoa looks like and contents of the pack mirvas
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to defend the body from infection and cancer . bevacsizumb binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found in lymph vessels all over the body . the vegfs protein causes blood vessels to expand , thus increasing their ability to receive oxygen . be vacizumsab slows tumour growth and
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you have been pregnant or breast - feeding . warnings and precautions talk to your doctor or pharmacist before using mvasi . before using or using mvai , tell your doctor if you : - have a history of developing holes in the gut wall ( inflammation inside the abdomen ) - have diverticulitis ( stomach ul
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer . the recommended dose is 5 mg , 7 . 5 mg or 10 mg , given once a week . the dose may be increased or decreased by up to 15 mg depending on your size and the amount of mvai you are receiving . your doctor may decide to increase your dose of the mvasis depending on how you respond to mvasic and on how well you tolerate it . if you respond well to mvais , it may be possible to receive mvasia 2
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects listed below are caused by mvasi and are caused not by the side effect itself . mvasis is given in combination with chemotherapy . if you notice any of these side effects while you are being given mvasic , tell your doctor straight away . allergic reactions tell your physician straight away if you have an allergic reaction , including : difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). other side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 unless dilution has taken place
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevaconizumumab in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active ingredient bevocizumb in 1. 4 ml of water for injection . each 16 ml vials contains 400 mg of of bevagacizumaab in 16 . 75 ml of solvent . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in combination with other medicines to treat refractory mantle cell lipoma ( mcl ). it consists of your own white blood cells ( called autologous anti - cd19 - transduced cd3 + cells ). mantle cell cancer is a cancer that affects the immune system , especially the b - lymphocytes . mantle cell lysis is a process in which b - cells multiply in an uncontrolled way and divide the lymph tissue in the bone marrow . tecartus works by attaching to the white blood cell in your blood . this allows
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using tecartuse if : you have a problem with the number of white blood cells in your blood ( lymphodepleting chemotherapy , see section 3 " how to use teCartus "). white blood cell are important for autologous use . your doctor will carry out tests and checks to check the number and location of your lungs , heart , kidney and blood pressure
your doctor will decide how much tecartus you will receive . your doctor will calculate the dose based on your own white blood cells . your cells will be given to you by a catheter placed in your vein ( a procedure call leukapheresis ). the number of your white blood cell in your blood will be calculated by your doctor . the recommended dose is one infusion of your blood into a vein every 3 to 6 weeks . the number and number of days you will be treated with your whiteblood cells will depend on how well you respond to tecartuse . the dose is 2 to 3 million cells per kg body weight
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will explain the risks and benefits of your treatment and what you should do if you experience any of the following side effects . you may need urgent medical attention . the following serious side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness ). decreased level of consciousness may be associated
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . infusion bag : store in the original package in order to protect from light . liquid nitrogen : the recommended dose is 150 mg . this medicine is made from genetically modified human blood cells and human - derived material . once thawed , the product should be used within 36 hours . do throw away any medicines via wastewater or household waste . ask your pharm
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3 + cells . each specific single infusion bag contains a dispersion of anti - cd19 car t cells equivalent to 68 x 2 cd3 cells per ml , corresponding to a concentration of 106 cd3 / ml . - the other ingredients are : anti - dna , sodium chloride , human albumin ( see section 2 " tecartuses contains sodium "). what tecartu looks like and contents of the pack tecartub is a clear , colourless to pale yellow solution for infusion , supplied in an infusion
januvia contains the active substance sitagliptin and belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which are used to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi if you have : - blistering of the skin - bullous pemphigoid ( januira is not recommended if you suffer from a disease of the pancreatreas called pancreatitis ) - gallstones - alcohol dependence - very high levels of triglycerides ( a type of fat ) in
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg . your doctor will tell you how many tablets to take . if necessary , your dose may be increased . taking this medicine your doctor can tell you to take this tablet with or without food . if your doctor prescribes certain other medicines that lower blood sugar , your risk of blood sugar may be higher . if this happens , you
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which might reach through to your back , nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing , stop
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . tablet coating : poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what januva looks like and contents of the pack
what xultophy is xultose reduces the amount of blood glucose produced by the body in patients with type 2 diabetes mellitus . diabetes is when your body does not make enough insulin , or the insulin that your body produces does not work as well as it should . this leads to an increase in blood sugar . insulin degludec is a long - acting basal insulin . it helps to control your blood sugar levels by lowering the amount liraglutide ( a substance present in glp - 1 ) and insulin during meals . what xultopy is used for xultine is used in combination with oral medicines
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). if you have 39 diabetes . if you take a sulfonylurea such as glimepiride or glibenclamide . your sulfonylation dose should be reduced to maintain your blood sugar levels . warnings and precautions talk to your doctor or pharmacist before taking xulture if you suffer from type 1 diabetes mellitus or ' ketoacidosis '. this is a condition which can occur when you take xulinophy .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your dose . your doctor will tell you how much xultophy to use . the usual dose is one 41 mg tablet of xultue per day to be taken orally with or without food . you should take xultute for 8 hours before or after food . if necessary , your dose may be increased . how to use xultury is supplied in a pre - filled dial - a - dose pen . the dose
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common ( may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( may cause brain damage ) can occur . if you have low blood sugars , your bloodugar level may go up . if low blood glucose is not controlled with hypoglycemia , contact your doctor straight away . see section " warnings and precautions " for more information . serious allergic reaction ( anaphylactic reaction ) ( frequency not
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening : do not store above 30 . store below 8 for 21 days . do away with xultophy once you have opened the blister . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what xultophy contains - the active substances are insulin degludec and liraglutide . each vial contains 100 units of insulin degluudec 3 . 6 mg liragolutime in 3 ml solution . each ml contains 300 units of diabetes deglUDec 10 . 8 mg liraaglectide . - the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xultphil contains sodium "). what xultos looks like and contents
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor 2 ]- erbb1 and her2 [ erbb2 - erbb3 ]. these proteins are involved in the growth of cancer cells . this medicine works by stopping the growth and spread of cancer proteins . this helps to stop the growth or spread of these proteins . your doctor has prescribed this medicine for you because you have a type of cancer of the lung ( non - small cell lung cancer ). giotriff is used as your first treatment after prior chemotherapy treatment
do not use giotrif - if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) - if your child has low body weight ( less than 50 kg ) - warnings and precautions talk to your doctor or pharmacist before using giotrinif if your baby has kidney problems , as this medicine may cause side effects such as lung inflammation ( interstitial lung disease ) - liver problems your doctor may need to do some liver tests before you start using this medicine - if the child has a severe liver disease - if he / she has eye problems - if they have severe
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take this with or just after food . you may take this this medicine with or with food . if you take more giotrinif than you should if you have accidentally taken too many tablets , contact your doctor immediately . if possible , take this leaflet with you
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment with giotreif : diarrhoea common ( may affect up to 1 in 10 people ): diarrhoehoea ( may cause up to 2 cases of severe diarrhoee with fluid loss ) common ( might affect upto 1 in every 10 people ) low blood potassium ( may result in worsening kidney function ) diarrhoeas if you experience diarrhoehea , contact your doctor immediately . appropriate antidiarrhoeal treatment is usually started at the same time as antidiarhoeal
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinab . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 . what giotreif looks like and contents of the pack giotrinif 20 mg film - coating tablets are white to off - white , round , biconvex , oval , bony
what orkambi is orkamsi contains two active substances called lumacaftor and ivacaftOR . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older with a mutation called f508del mutation . f508d is a protein that is found in cystic cystic fibre receptor ( cftr ) cells in the lungs . the mutation causes an abnormal cftR protein that cannot be controlled with lumacafor . how does ivacftor work ? lumacftOR works by blocking the abnormal cFTr protein .
do not take orkambi - if you are allergic to lumacaftor , ivacaft or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have orkababab , the f508del mutation may occur in some patients who are treated with orkaban . if this happens , your doctor may need to change your dose . - if your liver or kidney disease has been reported . the dose of orkibabab may need adjustment . - tell your doctor if you notice abnormal blood tests
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take adults the recommended starting dose is 6 to 12 tablets once a day . your doctor may increase your dose to a maximum of one orkambi tablet once a morning , once a afternoon , once in the morning , and once in a day , once at about 6 to 11 in the evening . your dose of orkandemi is 100 mg once a week for 2 weeks , then 2 tablets once daily for 12 weeks . your daily dose of eitherkambdi is 200 mg once
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi are usually mild to moderate . ivacaftor may cause serious side effects when taken with orkyambi . these include raised levels of liver enzymes in the blood , liver injury , pre - existing severe liver disease and the worsening of liver function . the following side effects have been reported : uncommon ( may affect up to 1 in 100 people ): - pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes - loss of appetite - nausea or
what orkambi contains the active substances are lumacaftor and ivacaftore . orkammi 100 mg , 125 mg , 100 mg lumacavor and 125 mg ivacavore . each tablet contains either 125 mg or 125 mg of ivacafor . orkyambi 200 mg , 200 mg or 200 mg lumasaftor : each tablet contain either 125mg or 125mg of iviacaftor . each orkabi 100mg or 200mg film - coated tablet contains : the active substance is either lumacafir or 125 μg of ivocaftor ( as
what lynparza is lynparaz contains the active substance olaparib . olaparateib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). parp inhibitors are used to treat mutations ( changes ) in a gene called brca ( breast cancer gene ). in some types of cancer , parp inhibitors can cause death . how lynparz works parp helps cancer cells by blocking an enzyme needed to repair dna . what lynpara is used for lynparanza is used to diagnose and treat ovarian cancer (
do not use lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). if you have been in close contact with someone who has had an operation in the past , please tell your doctor . see section 2 " warnings and precautions " for more information . if you think any of these apply to you , tell your physician before using lynparz . warnings and risks talk to your doctor before using the medicine . before using or during treatment with lynparaz , tell the doctor if you : have low blood cell counts ( seen in testing ). low counts of red
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . your doctor may increase your dose to 150 mg once daily depending on how you respond to the doses of lynpalza capsules . tablets are not interchangeable . if you take more than a capsule of lynperza once a night , you may experience side effects for up to 8 hours . take the tablet by mouth once in the evening . if possible , take it at about the same time each day . if necessary , take the tablets
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ): allergic reactions including hives , difficulty breathing or swallowing and dizziness . signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting ) feeling tired
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 30 . store at 2 to 8 in the original package in order to protect from light . after first opening , the capsules should be used immediately . do this if you notice any change in the appearance of the capsules . do away with any lynparza capsules that are damaged or shows signs of tampering . store the capsules in the outer
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg olaparateib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack lynparaz is a white , opaque , hard capsule imprinted with " olaparaib 50 mg " on one side and " astrazeneca logo on the other . lynparZA is available in packs containing 112
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine in adults . nyxoid is used as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children over 14 years of age . overdose can lead to breathing problems and severe sleepiness . the effects of an opioid overdose are similar to those of opioids but may be more serious . if you have any questions about how nyxoids works or why this medicine has been prescribed for you , ask your doctor or
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nyxoids . you may need emergency medical care or emergency services if you experience an opioid overdose . the signs and symptoms of an opioid dose are similar to those of an accidental overdose . you should use this nasal spray for 2 to 3 days before using a new nasal spray . if you use more nyxid than you should if you think you may have used more nixoid than you need , talk
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one spray . 1 . if symptoms occur , you should take the spray as follows : shoulders , ears , breastbone , sternum or inside the ear . fingernail . 2 . clear the mouth and nose of any blockers . do not open or close the mouth or nose . 1 ). if breathing is the chest moving ( chest ) you should hear breathing sounds and breath on the tongue . overdose may occur if the response to touch or sounds is slow uneven breathing , breathing
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and seek medical help immediately if you experience acute withdrawal symptoms from opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawalsymptoms may affect up to 1 in 100
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone . - the other ingredients are : ( hydrochloride dihydrate ), trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . what nyxoids looks like and contents of the pack nyxoidal is a 0 . 1 ml clear , colourless to pale yellow solution for injection in a pre - filled nasal spray . it is supplied in a single dose container . nyxax is available in a carton containing 2
what ovaleap is ovaleape contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). how ovaleaps works ovaleat is a type ( fsh ) produced by the body . it is involved in the growth and development of the sac ( follicles ) in the ovaries . it plays an important role in the production of sperm . it can be produced by a immature egg cell . it may be grown by treatment with a medicine called " clomifene citrate " or assisted reproductive technology procedures ( procedures that
do not use ovaleap if you are allergic to follitropin alfa or any other follicle stimulating hormone ( fsh ) or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ). if you think you have large ovaries or sacs of fluids that contain the ovaries . if you know that you have ovarian cysts . if any of these apply to you , tell your doctor . if your doctor thinks you have unexplained vaginal bleeding . if there is cancer in your ovaries , womb or breasts .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of this medicine is one injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , your doctor will give you this medicine once every day for the first 7 days of your menstrual cycle . the medicine will be given to you once a day . the recommended starting dose of the medicine is 75 mg . your doctor may increase your dose to 150 mg once a week . your dose of your medicine will usually be given once a month for the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects : - women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 common ( may affect up to 1 in 10 , 000 people ): if you have this type of reaction , your ovaleape injection should be stopped immediately . serious sideeffects in women lower stomach ache and nausea ( vomiting ) are the symptoms of ovarian hyper - stimulation syndrome ( ohss
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . do this medicine if it has been stored for more than 3 days below 25 . do away with this medicine and keep it at room temperature ( not above 30 ) for no longer than 3 hours . once removed from the refrigerator , the cartridge must be used within
what ovaleap contains the active substance is follitropin alfa . each ml of ovaleep 300 iu / 0 . 5 ml solution for injection contains 300 iiu ( 22 micrograms ) follitroin ala in 0 . 05 ml solution . each vial of ovatheap 450 iu/ 0 . 75 ml solution contains 450 iiu 33 microgram ( 23 microgram ) folliotropin alpha in 0. 75 ml . each cartridge of ovallap 900 iu per 1 . 5ml solution for injections contains 900 iiu of follitopin alga in 1 .
voriconazole accord contains the active substance voriconazol . voricoazole is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults and children from 2 years of age to treat : invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp ). candidaemia ( a kind of fun fungal illness caused by candida sp .) in non - neutropenic patients ( patients with abnormally low white blood cells count ) to treat candida spots infections caused by the fungus fluconaz
do not take voriconazole accord - if you are allergic to voricazole or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking any other medicines , including herbal medicines . the medicines listed below are taken before voricoazole accord treatment 46 terfenadine ( for allergy ) astemizole ( for allergic ) cisapride ( for stomach problems ) pimozide ( for mental illness ) quinidine ( for irregular heart beat ) rifampicin ( for tuberculosis ) efavirenz (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection . the usual starting dose is 40 mg once a day for up to 40 days . this will be increased every 24 hours to 400 mg once daily for up for 12 days . after 12 days , the usual dose is 200 mg once every 12 days for up and 24 days . thereafter , the recommended dose is 100 mg once per day . your dose may be increased to 300 mg once weekly for up until 40 days if you have
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , you should contact your doctor immediately . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice ( changes in blood tests of liver function ) and pancreatitis . other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision ), blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura
what voriconazole accord contains the active substance is voritazole . each tablet contains 50 mg of vorinazole ( as besilate ). each voricle of vorbiconazol accord 50 mg film - coated tablets contains 200 mg of the active ingredient voritonazole , each tablet of vORiconazoly accord 200 mg film film - coating the other ingredients are : tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose , titanium dioxide
mvabea is a vaccine to protect against ebola virus disease in the future . it is given to adults , adolescents and children from 1 year of age with ebolairus who are at risk of getting ebola . it follows a 2 - dose course of vaccinations . ebola is caused by the zaire ebolavirus and filovirus . this vaccine stops the spread of filov virus , which is the whole ebola virus , and gives you ebola disease . warnings and precautions : before vaccinations , you should receive zabdeno vaccine about 8 weeks later . mvabeas vaccine is not recommended
follow carefully all instructions given to you by your doctor , nurse or pharmacist . check with your doctor or pharmaceur if you are not sure . warnings and precautions talk to your doctor before you receive mvabea if you have : a severe allergic reaction ( see section 6 . if you think you may have a severe allergy reaction , ask your doctor for advice . if your doctor has given you an antibiotic called ' gentamicin ' that can be given with the vaccine . if any of the above applies to you ( or you are unsure ), talk to the doctor , pharmacist or nurse before you are given mvaga
the recommended dose of vaccine is given by injection into a muscle ( intramuscular injection ) in the upper arm , thigh or blood vessel . the recommended dose is one dose of vaccination with zabdeno vaccine 8 weeks later . if you are given more mvabea vaccine than you should the second vaccine will be given at the same time . the first vaccine is a type of vaccine called primary vaccination first vaccination with a zab deno red cap vial ( 0 . 5 ml ) second vaccination with mvabdenos yellow cap vials ( 0. 5 ml ). if you have missed an earlier zab
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth , swelling or where the injection is given very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) feeling sick ( vomiting ) itching where the vaccine is given uncommon ( may affects up to1 in 100 people ): redness or skin hardness where the needle is given generalised itching . the most common side effects are : common ( likely to affect up in 1 in < 1 in
what mvabea contains the active substance is zaire ebolavirus 29 produced in tai forest ebolovirus nucleoprotein marburg in 0 . 7 ml of solution containing 108 million cells ( chickenembryo fibroblast cells ). this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections and hydrochloric acid ( for ph adjustment ). what mvabaa looks like and contents of the pack mvagaa is a suspension for injection in a single - dose glass vial with a rubber stopper and yellow cap . each carton contains
ondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronat is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondronAT can also be used to : - reduce a raised calcium level in your blood because of a tumour . this helps to reduce the amount of calcium that is lost from your bones . this reduces the chance that your bones become weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronAT if you : have a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) you are taking bondroneat for the treatment of cancer or related conditions . onj can occur within a few days of stopping treatment . on j is a painful condition that can be difficult to treat . therefore , you should
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day for cancer . it is given as an infusion into your vein . your doctor will carry out regular blood tests before you are given bondronat . your dose of this medicine will depend on your illness . if you have breast cancer that has spread to your bones , it may be given as 3 - 4 tablets once a week . it may also be given by an infusion in your vein over a period of up to 15 minutes . if there is a raised calcium level
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in up to1 in 10 , 000 patients ) pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 . do this medicine if it is accidentally frozen . do throw away any medicines via wastewater or household waste . ask your pharmacist how
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion equivalent to 2 mg ibandronat . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack 1 ml vials with a bromobutyl rubber stopper .
what zeposia is zepoia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what zeposeia is used for zepoesia is given to adults to treat relapsing remitting multiple sclerosis ( rms ), a rare but active disease that affects the entire body . how zeposesia works multiple sclerosis is a disease that suppresses the immune system and hinders the body ' s defences . white blood cell ( lymphocyte ) are important for the nerves of the brain and spinal cord . they help to protect the nerves and help to prevent symptoms such as
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack ( angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred within the last 6 months . if your heartbeats ( arrhythmia ) are not working properly . if any of these apply to you , tell your doctor before taking zepo . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you :
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need based on your heart rate and will prescribe you a ' treatment initiation pack ' for treatment . the first 4 doses are 0 . 23 mg ozanimod per day . the second 1 dose is 0 . 25 mg ozamanod per morning . the third 1 dose ( 4 doses ) is 0. 51 mg ozmod per afternoon . the fourth dose ( 5 doses ) will be 0 . 48 mg oznomod
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( raised blood pressure uncommon ( may effect up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very rare ( may affects more than1 in 10 , 000 people ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynx ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine in the original package in order to protect from moisture . do do not take this medicine if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zepoesia 0. 46 mg : one capsule contains only 0 . 46 mg ozimod ( as hydchloride ) and zeposesia 0 92 mg : the active ingredient is ozimog (as hydrochlorides ). the other ingredients are microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate . capsule shell : 0 . 21 mg
temybric ellipta contains two active substances : fluticasone furoate and umeclidinium bromide , vilanterol . fluticastone fureate belongs to a group of medicines called corticosteroids ( steroids ). umeleclidinnium bromeide and vilansterol belong to agroup of medicines known as bronchodilators . what temybic ellipta is used for temy bric elliptea is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition that causes breathing difficulties .
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric ellipte - if your child has asthma . temyberric elliptoe should not be used in children with asthma . - if the child has heart problems . - in children who have high blood pressure . - for children who has liver problems . warnings and precaution talk to the doctor or nurse before using this
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . do not take more temybric ellipta than your doctor tells you to . if you use more tembric ellipta than you should if you have used more temphric elliptas than you have been told to , contact your doctor immediately . symptoms of temybreric elliptoe may include a sudden attack of breathlessness or wheezing . if
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing do not improve after taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung ) in copd is a common side effect that may occur after taking temybric ellipta . symptoms of a lung infection may include fever and chills , increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore or raised patches in the mouth or throat caused by a fungal infection (
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone fureate , 65 microgram of umeleclidine bromides and 55 microgram ( 23 microgram ) of umclidinate ( 22 microgram ), vilansterol and trifenatate . - the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptas contains lactose '), magnesium stear
zinforo is an antibiotic medicine that contains the active substance cefosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo can be used to treat infections of the skin , including the tissues below the skin . it is also used to prevent an infection of the lungs called ' pneumonia '. how zininforoe works zin foro works by killing certain bacteria that cause serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). if any of these apply to you , tell your doctor before taking zin foro . warnings and precautions talk to your doctor or pharmacist before taking this medicine if any member of your family has kidney problems . if your child has seizures ( convulsions ). if
the recommended dose of zinforo is 600 mg once a day . your doctor will decide how many doses you need . the recommended dose is 12 600 mg twice a day ( every 8 hours ). if you have some infections , your doctor may decide to increase your dose to 8 600 mg every 12 hours . zin foro is given as a drip into a vein ( intravenously ) over a period of 5 to 60 minutes . your dose may be increased to 120 mg once daily . your physician will decide whether you need an increased dose . duration of treatment your doctor should decide how long you should be treated . the usual dose
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects . if you get any of these symptoms , you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems . these could be signs of a severe allergic reaction ( anaphylaxis ). diarrhoea , stool , blood or mucus may occur during treatment with zinforo . this is more common with medicines used to slow bowel movement ( see section 2 ). your doctor may ask you to have a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine . what zinofo looks like and contents of the pack zinfforo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain : pregabalinpfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic Pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with
do not take pregabalin pfizer - if you are allergic to pregagabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregaboralin psfizer . some patients taking preginabalin have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which could increase the occurrence
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : the recommended dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregibalin psfizer . you should take pregaboralin pfeizer once in the morning and once inthe evening . if you weigh 59 kg or more , you should normally take pregaabalin pumpfizer once a
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability . disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregibalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregabialin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1521 ), potassium hydroxide . the 75 mg
xadago is a medicine that contains the active substance safinamide . it works by increasing the levels of dopamine in the brain . dopamine is a chemical in the body that is important for movement . it is important that everyone in the family has a functioning brain , and is important in controlling their movements . in parkinson ' s disease , many people have difficulties moving . xadago can be used alone or in combination with levodopa ( other medicines used to treat parkinson' s disease ).
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed any of any of these medicines : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , or tranylcypromine . before starting treatment for parkinson ' s disease or depression , your doctor may prescribe pethidine ( a strong pain killer ). if this applies to you , tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg twice a day ( 100 mg taken by mouth ). your doctor will tell you how many tablets of xdago to take . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg once a day . take xadadago at the same time each day . you should swallow the tablets whole with a glass of water . you can take xdadago with or without food . if taking more xadagon than you
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : hypertensive crisis ( very high blood pressure that may lead to collapse ) - neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia , increase level of enzyme creatine kinase in your blood ) - serotonin syndrome ( confused , hypertension , muscle stiffness , hallucinations ) - hypotension ( the following side effects have been reported with parkinson ' s disease in combination with safinamide and levodopa , but not with other medicines used to treat parkinson '. common ( may affect
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinam . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ). what xadag looks like and contents of the pack xadagon 50 mg film - coated tablets of 7 mm diameter with metallic gloss are marked with ' gsi ' on
zytiga is a medicine containing abiraterone acetate that is used to treat prostate cancer that has spread to other parts of the body . zytiga increases the levels of testosterone in your blood when you have prostate cancer . ztiga is used in patients who have disease that cannot be treated with hormone therapy , a treatment that lowers testosterone ( androgen deprivation therapy ). it is used when another medicine , prednisone , is not suitable . prednisolone is used for high blood pressure in adult patients whose body is not able to absorb the medicine properly and which causes fluid retention in your bloodstream .
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - if your partner is pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytigo - if the patient has severe liver damage - if he has prostate cancer . this medicine should not be taken with this medicine . talk to a doctor or nurse before taking this medicine - if any of these apply to you : - if this patient has liver problems - if they have high blood pressure or heart failure - if their doctor has told them that low blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor may increase your dose to 1 , 000 mg once a week . take this tablet at the same time each day . this medicine should be taken by mouth . swallow the tablet whole with a glass of water . you can take zytiga with or without food . if you take more zytige than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take your tablet with food . you may take zy
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . your doctor may decide that the level of potassium in your blood is low . your dose of potassium may need to be adjusted . other side effects include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet ( signs of low blood potassium , as shown by liver function test ) high blood pressure urinary tract infection ( signs include diarrhoea ) common ( might affect
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytig looks like and contents of the pack - zytige tablets are white to off - white , round tablets with a diameter of 9 . 5 mm . the tablets
what hefiya is hefiYA contains the active substance adalimumab . it is a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis , paedian crohn ' s disease and paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies attach to specific proteins in the body . addalimumab blocks the activity of a protein called tumour necrosis factor ( tnfα ), which is involved in the inflammatory diseases and reduces
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your baby has a severe infection , including tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections . if your newborn has unusual infections , including those caused by a weakened immune system . symptoms of infections may include fever , wounds , feeling tired , dental problems . if you have moderate or severe heart failure . if the newborn has a serious heart condition . warnings and precautions allergic reaction allergic reactions have been reported in patients receiving hefiye treatment . symptoms may include chest
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 40 mg once a day . your doctor may prescribe you a lower dose of 20 mg once daily . your child ' s doctor may decide to increase your dose to 20 mg or 40 mg twice a day depending on the response to the medicine . polyarticular juvenile idiopathic arthritis age and body weight how much to take adults , adolescents and children from 2 years of age weighing 30 kg or more 40 mg three times a day children from 1 year of age weighed 10 kg or less
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( which may occur up to 4 months after the last hefiya injection ): allergic reaction ( including heart failure ), severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . signs and symptoms of infection include fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre - used syringe may be used for a single period of
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalimab in 0 . 4 ml of solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiqa 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a type in white blood cell called b - lymphocytes . when ritukimab sticks to this surface , the cell dies . what ritemria is used for the treatment of ritemvi is used to treat : a ) non - hodgkin ' s lymphoma this is an uncommon form of a disease of the lymph tissue . the immune system ( the body ' s natural defences ) cannot attack a type or
do not use ritemvia if you are allergic to rituximab , other proteins that are similar to ritonuximb or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe active infection if you suffer from a weak immune system if you suffered from severe heart failure or severe uncontrolled heart disease if you know that you have granulomatosis , polyangiitis , microscopic polyangitis or pemphigus vulgaris warnings and precautions talk to your doctor or pharmacist before using ritemvi if you : have ever had or might now have a hepatitis
how much ritemvia is given your doctor will decide how much ritemvia you will receive and how often you will need this treatment . your doctor may decide to stop giving you this medicine if you get any side effects . how ritemv is given ritemva is given as a drip ( intravenous infusion ). medicines given before each ritemvi administration you will be given ritamvia together with other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . if you are being treated for non - hodgkin ' s lymphoma , you will usually be given one course of
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and will generally disappear after a few days of treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as besilate ). each vial of concentrate contents contains 10 mg of the active ingredient in ritiximab - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemstrivia looks like and contents of the pack ritemitri is a clear , colourless solution for infusion in a glass vial . pack size of 2 .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine . capecabine etva is used in the treatment of colon , rectal , gastric , or breast cancers . capectabine eteva is prescribed to be used in adults who have advanced stage of colon cancer after complete removal of the tumour by surgery . cape citabine
do not take capecitabine teva if you are allergic to capecitabanine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy to this medicine , ask your doctor for advice . warnings and precautions talk to your doctor before taking capecitafine tevas if you have : severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines containing fluorouracil ) if you ( or your partner ) are pregnant if you suffer from low levels of white cells or platelets in the blood ( leucopenia , neutropenia or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabiline teva is calculated from your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface taken once daily . this is equivalent to a daily dose of 64 mg . your child ' s height should be 1 . 64 m in height and
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you experience an increase of 4 or more bowel movements compared to your normal bowel movements , or any diarrhoehoea at night . vomiting : if vomiting is more severe than nausea . if you lose your appetite . stomatitis : if pain , redness , swelling or sores in your mouth and / or throat . hand and foot skin - reaction : if your doctor feels that you have pain , swelling ,
what capecitabine teva contains the active substance is capecitabiline . capecitavine teeva 150 mg film - coated tablets each film - coating contains 150 mg capecitobine . furthermore , capecitafine tevas 500 mg film film - coat contains 500 mg capecabine . the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hyproellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red (
silodosin recordati contains silodosino recordati . it belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodosein recordat is used to lower the pressure in the prostate , bladder and urethra . it helps to maintain smooth muscle in these tissues . this helps to reduce your symptoms . silosin Recordati is used in adults to : reduce the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to silodosein or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordat : - if your child is undergoing eye surgery - if there is cloudiness of the lens in the eye after cataract surgery 26 - if the child is being treated with silodmosin recordatri , medicine may cause a loss of muscle tone in the iris ( the coloured part of the eye ) during a surgery . your doctor will take appropriate precautions when changing
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of silodosin recordati is one capsule a day . you should take silodosein recordat for at least 8 hours every day . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . for this purpose silodosesin recordatin is for oral use . swallow the capsule whole with a glass of water . you can take silosinrecordati with or without food . you may take the capsule with or just after food
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions may include swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives . the most common side effect of silodosin recordati is dizziness . dizziness may also occur with occasionally fainting . if you feel weak or dizzy , contact your doctor . the symptoms of dizziness and fainty may be similar to those described below . if any of the above occur , stop taking silodnosin recordat and seek medical advice straight away . complications following a cataract
what silodosin recordati contains silodosein recordat 8 mg : the active substance is silodofin . each capsule contains 8 mg silodousin . the other ingredients are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). silodosesin recordatin 4 mg : each capsule contain 4 mg silosin . these ingredients are also mannola , magnesium starchearate, sodium lurilsulfATE , gelatin, titanium dioxide , yellow iron oxide ( e172 ). what silodosiin recordi looks like and contents of
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzalono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzialmonoes is used to treat essential hypertension ( high blood pressure ) in adults . essential hypertension is the high blood blood pressure that occurs every day . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if more than 3 months have passed since you last took a tablet . - if your doctor thinks you may be pregnant . ( it is also better to avoid kinzdalmono in early pregnancy see pregnancy section .) - if any of these apply to you , tell your doctor before taking kinzlmono . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have severe liver problems ( such as cholestasis or b
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . the tablets should be swallowed whole with some water . you can take kinzalmono with or without food . try not to take more than the recommended dosage . if you take more kinzdalmono than you should if you have taken more tablets than you have been told to , talk to a doctor or go to a hospital straight away . if possible , take the tablets with a glass of
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious and need immediate medical attention : sepsis ( often called " blood poisoning "), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) and cardiovascular events . uncommon side effects : uncommon ( may impact up to 100 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . once your medicine has been taken out of your refrigerator , it should be used immediately . do this if your kinzalmono tablet is damaged or shows signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol , magnesium stearate . what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round and flat . kinzallmono is available in blister packs of 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology in a laboratory by recombination with lonoctocog alfa . afstylfa is used to treat bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ). factor v ii is involved in blood clotting and is necessary for blood to clot . patients with an increased tendency to bleed have been shown to have higher levels of factor v viii in their blood than patients with no factor vii . therefore , patients with patients with a high risk of haemph
do not use afstyla if you have had an allergic reaction to afstya or if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using afststyl a . the batch number and frequency of administration are recorded in your treatment diary . do not use more afstylea than your doctor has recommended . allergic ( hypersensitivity ) reactions are very rare in patients receiving afstlya . symptoms of allergic reactions may include allergic reactions ( e . g . hives ), generalised skin rash , tightness of the chest , wheezing , fall
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the dose of afstyla you receive will depend on the severity of your disease the site and the bleeding your clinical condition . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be used immediately after preparation . if you have aseptic conditions , you may be given afststylas together with other medicines or solvents . see section 6 . the solution should be
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash , tightness of the chest , difficulty in breathing , wheezing ), low blood pressure , dizziness ( anaphylaxis ), bleeding which may occur in patients taking factor viii medicines . inhibitor antibodies ( see section 2 ) may affect up to 1 in 10 people . patients who have received previous treatment with factor v iii ( more than 150 days of treatment ) may experience an increased risk of developing a condition called "
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the reconstituted product should be used immediately . do away with the vial and any unused product . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu ( 2 . 5 mg ) of lonoectocog aluminium . after reconstitution with 2 .5 mg of loroctococog aluminum and injections the solution contains 200 iu lonoCTocog alpha . each 1000 iu vial provides 50 iu of lonctocag alfa per ml . after initial reconstation with 2. 5 mg of injections the product contains 400 iu / ml lonoictocog α . each 1500 iu or 5 ml
what praxbind is prax bind contains the active substance idarucizumab . idarukizumb is a recombal agent . it is used in combination with dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . what praxBind is used for praxbinding is used to rapidlytrap dabigATran . what it is intended for praaxbind is used when pradxa is not used in patients who are undergoing emergency surgery or who require urgent procedures to stop uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( haf ) that is not controlled by the substance sorbitol . warnings and precautions talk to your doctor or pharmacist before taking this medicine if any of these apply to you . serious adverse reactions have been reported with the use of prax bind in patients taking this type of medicine ( dabigatran ). other medicines and praxBind tell your doctor if you take , have recently taken or might take any other
the recommended dose is 5 mg / kg . your doctor will decide the dose that is right for you . your dose will be calculated by your doctor based on your body weight . the recommended dose for adults is 2 . 5 mg dabigatran per kg body weight , given once daily . this medicine will be given to you once daily for 5 days . this will be administered into a vein . your healthcare professional will administer this medicine to you at regular intervals . your treatment will be closely monitored by your healthcare provider . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what praxbinding looks like and contents of the pack prax bind is a clear to slightly opalescent , colourless to slightly yellow solution supplied in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . temmedac is first given together with radiotherapy ( concomitant phase of treatment ) and then monotherapy phase oftreatment ( phase 3 ). - in adult patients with malignant glioma , such as glioclastoma multififorme or anaplastic astrocytoma . temormac is given in combination with standard treatment .
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction may include feeling itchy , breathlessness , wheezing , swelling of the face , lips , tongue or throat . if certain types of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells help fighting infection by preventing proper blood clotting . your doctor will monitor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take with temomedic to prevent nausea and vomiting . if you currently have newly - diagnosed glioblastoma multiforme , treatment will be divided into two phases : treatment with radiotherapy ( concomitant
like all medicines , this medicine can cause side effects , although not everybody gets them . if you experience a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), uncontrolled bleeding , seizures , convulsions , fever , chills and severe headache , you should immediately stop temomedac treatment . a reduction in certain kinds of blood cells ( increased bruising or bleeding ), anaemia ( reduced number of red blood cells ), fever and reduced resistance to infections may occur . the reduction in blood cell counts is usually short - lived and can lead to anaemia (' aplastic anaemia '). your doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do use temomedac if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . temomeda 5 mg : each capsule contains 5 mg temozoleomide ( as mesolomides ). temomedax 20 mg :each capsule contains 20 mg tem ozolomine ( as temolomix ). temmedac 100 mg : every capsule contains 100 mg temzolomile ( as Mesolomid ). temarthac 140 mg : one capsule contains 140 mg temizolomime ( as esolomod ). temarmac 180 mg : the active ingredient is temazolomamide ( as bis
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis will only help you to obtain a hard erect penis when you have agreed to it . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by blocking the blood vessels in your penis . this allows your penis to work normally and allows you to achieve erectile function . ceralis is used to treat adult men who have erectile disease . c
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are intolerant of organic nitrate or nitric oxide donors such as amyl nitrite ( a group of medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor or pharmacist before taking ciali . if you have recently had a heart attack or within the last 90 days . - if recently had or have had a stroke within the past 6 months
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with a glass of water . the tablets can be taken with or without food . the usual dose is between 5 mg and 2 . 5 mg . if you take more cialises than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show them the pack . if necessary , show the doctor the pack of tablets . if not , show it to your partner
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes ) ( frequency not known ) chest pain ( may occur with nitrates ). ( frequency unknown ) priapsim may cause a prolonged and possibly painful erection . if this happens , stop taking cialis and seek medical help straight away . if you get an erection that lasts more than 4 hours , contact your doctor immediately . sudden loss of vision ( frequency cannot be estimated from the available data ). other side effects very common ( may affect more than 1 in 10 people ) uncommon
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' cialises contains lactose '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e129 ),
enyglid is an oral antidiabetic medicine containing repaglinide , which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body is not able to use the insulin it produces effectively . enyglID is used to treat type 2abetes in adults . treatment is usually started with diet and exercise and weight reduction . your bloodugar may be increased when you start taking eny glid on its own or with metformin . you may continue to
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking eny glid if : you have liver problems . you have moderate liver 28 disease
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . you may take enysglid for up to 30 minutes before or up to 4 hours after food . if you take more eny glid than you should if you accidentally take too many enylid tablets , contact your doctor straight away . if possible , take the tablets with a meal or snack . you might get
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of enyglid is hypoglycasemia ( very common : may affect more than 1 in 10 people ). hypoglycemic reactions are generally mild / moderate . hypocaemic unconsciousness may lead to coma . allergy allergy ( rare : may affects up to 1 in every 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects include : common : ( may affect up to1 in 10
what enyglid contains - the active substance is repaglinide . each 0 . 5 mg / 1 mg / 2 mg film - coated tablet contains repagginide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) ( only in 1 mg tablet ) and red iron oxide (> e172 ). see section 2 " eny glid contains lactose ". what eny
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine mylon is used for azac citidine myla is used to treat adults with certain types of myelodysplastic syndromes ( mds ). these include chronic myelomonocytic leukaemia ( cmml ). acute myeloid leukaemic ( aml ). aml is one of a group of diseases which affects the bone marrow , interfering with normal blood cell production . how azacnitidine myelan works azacituidine mygal stimulates the production
do not take azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitine mylan : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if you have a heart condition that puts you at risk of heart attack or lung disease . blood test before
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will decide how much azaccitidine myl is needed . your dose will be adjusted by your doctor based on your height and weight . azacacitine mylan is given every 3 weeks as part of this " treatment cycle " ( cycle 4 , 6 ). this medicine is given under the skin ( subcutaneously ) by subcutaneous injection ( sublingual use ). this is done under the sun ( sublimation ) or on the skin of
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may all be symptoms or signs of kidney failure . a fever , which might be a sign of an infection due to low levels of white blood cells .
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . after first opening : 1 ml of the azaccitidine myl suspension for injection , followed by injections . the suspension should be used within 8 hours . 2 ml of solution for injection : the azacsitidinemylan suspension for injections should be stored within 8 days . 22 ml of water for injections :
what azacitidine mylan contains the active substance is azacinidine . one vial of powder contains 100 mg azacacitine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . the other ingredient is mannitol ( e421 ). what azacididine myl looks like and contents of the pack azacnitidine mylon is a white powder for suspension for injection in a glass vial containing 100 mg of azacilitidine . it is supplied in packs containing 1 or 7 vials . not all
duotrav eye drop solution contains two active substances , travoprost and timolol . travostrost is a prostaglandin analogue in the eye . timolole is a beta blocker that reduces the amount of fluid within the eye and so reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye in adults with an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( e . g . wheeziness , difficulty in breathing , long - standing cough , breathing problems , severe hay fever ). - tell your doctor if your baby has a slow heartbeat . - if he / she has heart failure ( a disorder of heart rhythm , irregular heartbeat ), or if the coloured part of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the affected eye or eyes twice a day . your doctor will tell you how many drops of duotrav to use . how to use your eyes use duotrel as directed by your doctor . how long to use duetrav is for oral use . you should use it with a glass of water . you can use duots with or without food . how often to use eye drops : 1 drop in each affected eye twice a week , 2 drops
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will decide how to treat them . the drops should be used every day . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) effects affecting the eye eye redness . common side effect ( may effect up to 1 in every 10 people ), effects affecting only one side of the eye surface inflammation or surface damage . eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms include eye irritation , burning and stinging . uncommon side effects these may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substances are travoprost and timolol . each vial contains 40 mg travaprost and 5 mg timolole ( as timolols maleate ). - the other ingredients are polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg - the ingredients are : boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride and hydrochlorIC acid . acidity levels and ph levels are checked at regular intervals . what duotra
nplate ' s active ingredient is romiplostim . it is a protein that helps to reduce low platelet counts caused by the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body ' s immune system . itp reduces the number of platelets in your blood , which helps to prevent blood clots from forming . very low platelets can lead to bruising and serious bleeding . nplate is used to treat adults , adolescents and children aged 1 year and above who have had their spleen removed and who have chronic itp . it
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been taking other medicines containing escherichia coli ( e . coli ). warnings and precautions some patients taking nplate have developed a low blood platelet count ( thrombocytopenia ). your doctor may reduce your dose of nplate or temporarily stop it . your platelet counts may increase if you get blood clots . blood cl clotting may be a problem in some patients with liver
always use nplate exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( from 1 to 17 years of age ) the recommended dose of nplate is one tablet once a day . nplate should be injected under the skin ( subcutaneous ) at least 1 hour before or one hour after food . n plate should be used every day . your doctor will check your platelet counts regularly . you will have regular blood samples taken to measure your platelets . your platelelet count will be checked regularly by your doctor . the amount of n plate in your blood
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache , allergic reaction , upper respiratory tract infection common ( might affect up in 1 in every 10 people ) bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin , flushing , blood clot in a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , ind
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with this medicine if you notice it is not clear or if there are particles in it . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains - the active substance is romiplostim . nplate 125 mg powder for solution for injection contains approximately 230 mg romiploseim . each vial contains 125 mg romplostim in a deliverable amount of 0 . 25 ml solution . each single - dose vial provides 125 mg of romiplothim in the solution . n plate 250 mg powder : each single dose vials contains 375 mg romclostim and 250 mg romphostim ( in a deliveryable amountof 0 . 5 ml solution ). each single single -dose vial delivers 250 mg of the active ingredient romipl
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten , making breathing difficult . this medicine works by tightening these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - kidney problems - if your doctor has told you that you have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). your doctor may decide to temporarily stop treatment with tovannor breezer . if you have any of these conditions , stop using this medicine and tell your doctor immediately . - tightness of the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose is one inhalation once a day . this medicine is for use in adults , adolescents and children aged 24 years and over . the recommended starting dose is 75 inhalations once a week . your doctor will tell you how many capsules to use each day . how to use this medicinal product this medicine comes as an inhaler and capsules ( in blisters ) that contain the medicine . the medicine is inhaled using inhalation powder . the capsules
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms glycopyroniumbromide equivalent to 50 microgram of glycopYRronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram glycopyrsronium per inhalation dose . - the other ingredients are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovannor breezer 44 microlitre inhalation powder
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which have important calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms such as ( schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour , emotional flatness , depressed , guilty , anxious or tense . in people with bipolar disorder , these can include feeling " high ", having excessive amounts of energy , needing much less
do not take adasuve if you are allergic to loxapine or any of the other ingredients of adasuvey ( listed in section 6 ). if you have ever had symptoms of wheezing or shortness of breath , as these may be signs of lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness or short shortnessof breath 25 if you suffer from neuroleptic malignant syndrome ( nms ), which is a group of symptoms that have been reported in patients taking antipsychotic medicines .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day , taken at the same time each day . your doctor may increase your dose to 2 mg twice daily or to 4 . 5 mg twice weekly depending on your condition . adasuve is for oral use . you can take adasuva with or without food . it is best to take adasve with a meal . you should take adamsve with or just after a meal , preferably at the usual time . you may find it easier to take
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following side effects : any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness that becomes irritating and affects your airways ( asthma or copd ), light - headedness or fainting . these may be signs that your blood pressure is getting too high . worsening agitation , confusion , fever and muscle stiffness . these could be signs of a severe condition called neuroleptic malignant syndrome . other side effects include : very common ( may affect more than 1 in
keep out of the reach and sight of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with adasuvet if you notice any visible signs of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxapeine . after dilution , each single dose delivers 4 . 5 mg loxagine . what adasuves looks like and contents of the pack adasuva 4 . 05 mg is a white to off - white plastic inhaler with " lox " printed on the cap and " gsi " printed in black on the body . each inhaler is packed in a sealed foil pouch . adasuved 4 . 0 mg is available in packs containing 1 or 5 inhalers . not
what azacitidine betapharm is azaccitidine betabarm is an anti - cancer agent . it belongs to a group of medicines called ' anti - metabolites '. what azacididine betafarm is used for azacitonidine betaparm is a stem cell transplantation for the treatment of : - higher - risk myelodysplastic syndromes ( mds ) - chronic myelomonocytic leukaemia ( cmml ) - acute myeloid leukaemic ( aml ). aml is one of a group diseases which affects the bone marrow , interfering with normal
do not take azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitine betapham - if : you have decreased counts of platelets , red or white blood cells - you have kidney disease - you suffer from liver disease - if any of these apply to you , tell your doctor before taking this medicine . - you are at risk of developing a heart condition ( such as
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg . your doctor will decide how much azacita betapham you need and will tell you how many tablets you need . your dose of this medicine will depend on your height and weight . azaccitidine betafarm is given every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) by subcutaneous injection ( sublingual use ). it is given by sublinguate injection ( under the sun ).
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may all be symptoms or signs of kidney failure . a fever , which might be a sign of an infection due to low levels of white blood cells .
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . after first opening of the vials , the suspension should be used within 45 minutes . the azaccitidine betabarm suspension should not be mixed with water for injections . the suspension must be stored in a refrigerator ( 2 8 ) for up to 8 hours . the zacitine betapharms suspension should
what azacitidine betapharm contains - the active substance is azacito . each vial contains 100 mg azacitaidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . - the other ingredient is mannitol ( e421 ). what azacituidine betafarm looks like and contents of the pack azacididine betabarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacinidine .
what cerdelga is cerdelgoglobat contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher is inherited condition in which a substance called glucosylceramide is not removed from your body . this substance is mainly produced by the spleen , liver and bones . how cerdelgi works eliglustit works by blocking the action of glucosyleceramide in your affected organs . this medicine will help you to move more quickly and to reduce the effects of this medicine . what cerdelaga is used to use cerdelgas is
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - if your body is not able to tolerate medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 - if the body is unable to tolerate moderate cyc3a inhibitors ( such as erythromycin or itraconazole ). your doctor will tell you whether you should take these medicines , if they are not suitable for you , if your condition is not well controlled , if you have not taken cer
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet twice a day with food . the amount of metaboliser that you need to take depends on the level of metabolisation that you are taking . the usual dose is two tablets twice a morning , one tablet once a day . swallow the tablets with a glass of water . the maximum recommended dose for adults is 84 tablets once a morning . to take cerdelga , remove the blister / wallet from the pocket and take the sleeve from the blister . pinch your thumb with your finger .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustate . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ), shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack cerdelgas
the active substance in zoledronic acid hospira is zoledron acid , which belongs to a group of substances called bisphosphonates . zoledor acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the rest of bone ). to reduce the amount of calcium in the blood in adult men where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of
your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment regularly during treatment . do not take zoledron acid hospir if you are allergic ( hypersensitive ) to zoledor acid , another bisphosphonate ( the group of substances which zoledic acid belongs to ) or any of the other ingredients of zoledicle acid hospiar ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking zoledric acid hospire : if you have or have had a kidney problem . if you experience pain , swelling or
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ) and under ' iv ' administration . in order to avoid dehydration , you will be given one infusion of zoledronic acidic hospira every 4 weeks . if you have a kidney problem , your doctor may decide to reduce the dose depending on your kidney problem . your doctor will also tell you how much zoledic acid hospir you need to take . if your doctor determines that you have an increased risk of bone complications due to bone metastases , your first infusion of the year will be postponed
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain specific blood tests ) low level of calcium in the blood uncommon ( may effect up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth or jaw discharge , numbness or a feeling of heaviness in the jaw , or loosening of a tooth . these could be signs of bone damage in the
keep out of the reach and sight of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zoledronic acid hospira contains - the active substance is zoledron acid . one vial contains 4 mg zoledrin acid . - the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledic acid hospir looks like and contents of the pack zoledicle acid hospire is a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains one vials of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nausea ) or being sick ( vomiting ) when cancer treatment chemotherapy is used . chemotherapy destroys nerve cells in the brain , causing people to experience vomiting , being sick and being sick . rolapit works by stopping these nerve cells from working properly , and reducing the chance of nausea and vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if your doctor has prescribed varubry for you . if you have depression or difficulty sleeping ( see section 2 " warnings and precautions "). if you think this applies to you , tell your doctor before taking this medicine . warnings and conditions 27 if you suffer from severe liver or kidney problems . if your dose of certain medicines ( e . g . rifampicin ) is too
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . you may take it with or just after food . it is best to take the tablet at the same time each day . you should take it at least 2 hours before or 2 hours after food , at the start of your chemotherapy cycle . if you take more varubys than you should if you have taken more tablets than you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swellingof skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , as appropriate treatment may be needed . other side effects include : very common ( may affects more than 1 in 10 people ): headache , constipation , feeling tired uncommon ( may effect up to1 in
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg rolapit . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . tablet coat : blue 100 mg film - coated tablet , with
what enerzair breezhaler is and how it works enerzaire breez inhaler contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and microcopyrroneium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs . this helps to open the airways wider and allows air to get in and out of the lungs more easily . mometsone furate belongs to a class of medicines known as corticosteroids . corticoposteroids
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice before using enerzir . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : - have heart problems - have an irregular or fast heartbeat - have thyroid gland problems - suffer from diabetes , high blood sugar , seizures - have severe kidney problems - or have severe liver problems - notice a low
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should inhale the medicine at the same time each day . use enerzair breezhaler every day , at the right time of the day . this will help control your asthma and will help you to stop your symptoms getting worse . use in children and adolescents use in adolescents use of enerz air breez inhaler is not recommended in children or adolescents . how to use enerzezhalER is provided as an inhaler and capsules
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop taking enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives . these may be signs of allergic reaction . other side effects other side side effects include the following listed below : very rare ( may affects more than1 in 10 , 000 people ): sore throat , runny nose , sudden difficulty breathing ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used immediately after opening . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacatersol ( acetate ) and 63 microgram of glycopyronium bromides . each delivered dose contains 50 microgram ( glycopierronium ) and 160 microgramm ( mometsone furuate ). - the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 114 microgram / gram of ind
clopidogrel acino pharma gmbh contains the active ingredient clopidocar which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrelacino pharmá gmbhs is taken by adults to prevent blood cl clots ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ,
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopiprel or any of the other ingredients of clopidineogrel agabilate ( see section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , do not take the next dose of clapidogl acino pharma gmbhl . if your doctor thinks that you are not suitable for clopidiogrelacino pharm
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopidine acino pi gmb h per day to be taken orally with or without food . you can take cloclopidoggingrel acine pharma h for as long as your doctors prescribe it . if you take more clopidoogrelacino pharmh than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding . if
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 5 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ). very rare ( affecting less than1 user in 1, 000 ). not known ( frequency cannot be estimated from the available data ) contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be due
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplogrelacino pharmh if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmh looks like and contents of the pack clopidiogrel acidacino ph
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are taking medicines called ' antiretroviral medicines '. it contains the active substances doravirine ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and lamivudine ( also known as a nucleosidermal necrolysis ). it contains tenofovir disoproxil ( also called a nucleoide analogue reverse transcriptases inhibitor ( rtti ). delstrigo can be used alone or in combination with other medicines for hiv infection in adult
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of any of these , tell your doctor or pharmacist . if your doctor has prescribed any of them . if any of you are taking any of : - the following medicines : carbamazepine , oxcarbazepine ( medicines to treat tuberculosis ) - st . john ' s wort ( hypericum perforatum ), a herbal remedy used to treat depression and anxiety . - products
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet should not be used for treating hiv infection . the usual dose is 1 tablet a night . if you take certain medicines ( such as doravirine ) your doctor may prescribe medicines that lower the dose of this medicine swallow the tablet whole with a glass of water . if possible take this tablet with food . if your doctor advises you to take delstrigo for longer than 12 hours , consult your doctor . your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea , stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion and suicidal thoughts 45 trouble concentrating
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are : 100 mg doravirine ( equivalent to 300 mg lamivudine ), 245 mg tenofovir disoproxil ( as fumarate ), croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumar , and a coating material containing carnauba wax e903 . the other ingredients are : hypromollose , iron oxide yellow ( e172 ), lactose monohydrate
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression . it also helps to reduce the symptoms of depression , such as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and a feeling of being slowed down . spravato is used in combination with another antidepressant , which is also used in children and adolescents ( aged 2 years and above ). there is a lack of experience with antidepressant medicines in children .
do not take spravato - if you are allergic to esketamine or any of the other ingredients of ketamine ( listed in section 6 ). - if your doctor has told you that you have an aneurysm ( a weak spot in a blood vessel wall that bulges out due to bleeding in the brain ). - have recently had a heart attack . within 6 weeks of starting treatment , you may experience a temporary increase in blood pressure . serious complications in these conditions can occur during treatment with spravate . tell your doctor before taking this medicine if any of these apply to you . if you have a heart problem ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much spravato to use the spravat nasal spray is a single dose . the nasal spray device is only suitable for use in children and adolescents . the recommended dose is 1 spray device per kg body weight . the maximum recommended dose for children is 2 sprays per kg of body weight per kg . the total number of 3 nasal spray devices is one nasal spraydevice per kg weight per day . the dose for adults is 4 sprays ( 4 spray devices per kg ) per kg per kg
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected from other feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to touch in the mouth area spinning sensation vertigo vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy ( euphoria ) feeling agitated feeling anxious feeling in the eyes or ears a crawling feeling where your sense of touch are impaired or mimicked irritable panic attacks change in perception
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravatos looks like and contents of the pack spravat is a nasal spray solution . this medicine is a clear , colourless solution for use in children . it is supplied in a single - use nasal spray unit . spravati is available in packs containing 1 , 2 , 3 or 6 nasal spray devices . each
zerboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . this type of cancer is caused by a change ( mutation ) in a gene responsible for producing melanoma cells . zelboraf targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ) - if symptoms of allergic reactions ( such as swelling of the face , lips or tongue , difficulty breathing , rash , or fainting sensation ) occur . warnings and precautions talk to your doctor or pharmacist before using zelberaf . allergic reactions if allergic reactions occur , stop using zezboraf and tell your doctor immediately . if you have any symptoms of an allergic reaction ( such : swelling ofthe face , lip or tongue ), difficulty breathing or rash ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day for 8 weeks . your doctor may increase your dose to 4 mg twice a day if you get side effects . your treatment with zelboraf may be stopped if you experience vomiting . take zelberaf once a morning . take the tablet at about the same time each day . it is best to take zilboraf on an empty stomach . swallow the tablet whole with a glass of water . do not crush or chew the tablet . if you take
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelberaf and tell your doctor immediately if you notice any of the following : radiation treatment tell your nuclear medicine doctor immediately : if you have any of these following symptoms : skin rash , blistering , peeling or discoloration of the skin shortness of breath , a cough , fever or chills ( pneumonitis ) difficulty or pain when swallowing , chest pain , heartburn or acid reflux ( esophagitis
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this after the first opening of the blister . do away with the blister after this period . do no damage to the blister if you notice any visible signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of veMurafenb ). - the other ingredients are : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating containing iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack z
duoplavin contains clopidogrel and acetylsalicylic acid ( saa ). it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood vessels become thinner . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken to prevent blood clubs forming in hardened arteries , a process known as atherostrombotic events , which can lead to stroke ,
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( saa ) or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to other products called non - steroidal anti - inflammatory products if you have painful and / or inflammatory conditions of muscles or joints if you suffer from a medical condition ( such as asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ) if your doctor has told you that you have a medicalcondition that is currently causing bleeding such as a stomach
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many tablets of duoplavin to take and how long you should continue to take your medicine . your dose will depend on your condition and on how well you respond to duoplin . if you have had a heart attack , your doctor may have given you duopllin at a lower dose . if this happens , contact your doctor , pharmacist or your nearest hospital emergency department because of the increased risk of bleeding . if possible take duoplain with food
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine in the original package in order to protect from moisture . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 mg of the active substances , clopidogrel , acetylsalicylic acid (asa ), and acetylsuxypropylcellulose ( e464 ). each 75 mg tablet contains clopridogrel ( e463 ), and hydrogen sulphate ( e487 ). each each 75mg tablet contains acetylsolicylicacid ( e468 ), mannitol ( e421 ), macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylecelluloses , maize starch , hydrogen
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonididine tartrates belongs to the group of medicine called alpha - 2 adrenergic receptor agonists , which reduce pressure within the eye . simbrinz is used to treat pressure in the eyes in adults aged 18 years and older who have eye conditions such as glaucoma , ocular hypertension ( high pressure on the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides if you have ever taken medicines for diabetes or infections if you take diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors if you do not take medicines for depression or parkinson ' s disease if you currently take certain antidepressants . if you previously take any antidepressant medicines , including any antidepressant medicine . if any of these apply to you , tell your doctor
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza is for use in both eyes . use in the eyes only . avoid touching your eyes or eyes with your hands ( see section 1 , " how to use simbrinusza "). twist off the cap and snap collar . hold the medicine with your fingers . tilt your head back . pull down your eyelid with a clean finger and squeeze until there is a ' pocket ' between the eyelid and the eye . the drop will go in here ( see step 1 ). hold the bottle
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : - if you have a reaction to the medicine ( frequency not known ): - if an allergic reaction occurs , you may experience severe skin reactions ( such as rash , redness , itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat ). contact your doctor immediately - if extreme tiredness or dizziness occur . the other side effects that may occur with simbrinza are : - when simbratinza is taken with other medicines containing brinzol
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 mg of a brimonine tartrate equivalent to 1 . 3 mg of an aromatase inhibitor ). the other ingredients are : brimonide , benzalkonium chloride ( see section 2 " simbrinusza contains benzalkonaium chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid , sodium hyd
filgrastim ratiopharm contains the active substance filgrastam . filgrasterim is a protein produced by biotechnology in the body called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . filfilastim stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells help your body fight infection . filgnastim helps to increase the number of white blood cells in your body . you will
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrasteim or any of the other ingredients of filgrateim ratinopharm ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using filgrustim ratisopharm if you : - have a cough , fever or difficulty breathing - have or have had a pulmonary disorder . tell your doctor straight away if you get any of these side effects . - have sickle cell disease 57 - have left upper abdominal pain or pain at the tip of your shoulder - have had or
how much filgrastim ratiopharm is given the amount of filgrasteim ratisopharm you will be given will depend on your condition and on how well you respond to filgrasim ratitopharm . how often filgrate ratiapharm is used filgrasterim ratim ratidopharm treatment will be started by a doctor who is experienced in the treatment of cancer . the usual dose is 0 . 5 mg per kilogram bodyweight given every day for 60 days . your doctor will decide how many days you should receive your treatment . the maximum recommended dose is 14 mg per
like all patients , you should be carefully monitored by your doctor , pharmacist or nurse if you have sickle cell disease 57 you should feel left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of a spleen disorder . see section 4 . if you experience any of the side effects above , your doctor may order regular blood tests . filgrastim ratiopharm reduces the number of neutrophils ( a type of white blood cells ) in your blood . this will be checked before and during treatment . other medicines and filgrasteim ratim ratilopharm tell your doctor
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do do not take filgrasteim ratisopharm if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains the active substance is filgrasim . each ml of solution for infusion contains 60 mg of filgrasteim . filgrasterim ratisopharm 30 mg : each pre - filled syringe contains 0 . 5 ml of filgnastim . 50 mg : one pre - drawn syringe containing 0 . 0 ml of filmgrastime ratispharm 48 mg : the active ingredient is 48 mg filgracyim . the other ingredients are sodium hydroxide , glacial acetic acid , sorbitol , polysorbate 80 and water for
what riluzole zentiva is riluxole zenziva contains rilusole which is a substance that is produced by the nervous system . what rilzole zsentiva is used for rilizole zertiva is given to adult patients with amyotrophic lateral sclerosis ( amy ), a form of motor neurone disease in which the nerve cells that carry muscles out of control have a reduced supply of energy , weakness , muscle waste and paralysis . this causes the destruction of nerve cells . in motor neurONE disease , too much glutamate ( a chemical messenger ) in the brain and spinal cord can
do not take riluzole zentiva - if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have any liver disease . - if the medicine has increased blood levels of some enzymes of the liver called transaminases . - tell your doctor if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking rilzole zenta - if any of these apply to you . - you may develop any liver problems , such as yellowing of your skin or the whites of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be taken by mouth at least 12 hours before or after a meal . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible take rilizole zenta with food . if a child swallows some tablets , contact your physician immediately . do not take a double dose to make up for a forgotten dose . if your child swallips some tablets whole
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ) during treatment with riluzole zentiva . this may be due to a decrease in the number of white blood cells . your doctor will take a blood sample to check white blood cell counts and may adjust the dose if necessary . infections tell your doctor if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your
what riluzole zentiva contains the active substance is rilizole . the other ingredients are : - core : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide . what riluxole zenta looks like and contents of the pack the tablets are white , round and scored with a diameter of 50 mm . rilzole zintiva is available in packs containing 202 tablets . rilanuzolezentiva
emgality contains the active substance galcanezumab , a medicine that blocks the activity of calcitonin gene , a protein involved in migraine . increased levels of cgrp in the blood can lead to migraine . emgality is used to treat migraine in adults , adolescents and children aged 4 years and above who have migraines . emigality has been shown to reduce the frequency and severity of migraine headache and improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease . serious cardiovascular diseases can cause allergic reactions emgally can cause serious allergic reactions . these reactions may occur up to 40 minutes after you have had a serious allergic reaction . you should see your doctor immediately if you experience such signs or possible side effects as described in section 4 . children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and emgali tell your doctor or pharmacist if you
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg emgally given as an injection under your skin ( subcutaneous injection ). you may receive your emgalis injection at home or at a hospital or clinic where you receive proper training . if you receive more emgals than you should if you have received more than 240 mg , tell your doctor . do not give a double dose to make up for a forgotten dose . if your doctor thinks that you have not received emgalia properly , he or she will give
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash with raised bumps . other side effects tell your doctor or nurse if you notice any of the following : very common side effects ( may affect more than 1 in 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , the product can be stored for up to 7 days below 30 . do this until the doctor tells you otherwise . do away with this medicine before you use it . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumumab in 1 ml solution . - the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the colour is clear to slightly yellow . the syringe is supplied as single - dose pen in packs of 1 , 2 or 3 pre - fill
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hepatic vesicular disease ) in which the blood vessels in the liver are damaged and blood clots form . it can be given alone or with medicines obtained prior to a stem cell transplantation . defibrobrotide works by helping the blood arteries to open and close , so that the blood clasts can be removed . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you have previously used other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if any of these apply to you , tell your doctor or nurse before using this medicine . warnings and measures talk to your doctor , pharmacist or nurse immediately if you : - have bleeding , especially if it is heavy bleeding ( for example if you need a blood transfusion or surgery ) - have problems with blood circulation ( a constant blood pressure ) if your
the treatment with defitelio will be started by a doctor who is experienced in the use of stem cells transplantation . it will be given into one of your veins ( known as an ' intravenous infusion ') or drip . you will be monitored during this treatment for 21 days until your symptoms improve . children and adolescents the recommended dose is one tablet per kg body weight , given once daily . adults and adolescents ( aged 18 years and over ) the recommended starting dose of defitelo is one half tablet per day . if you miss a dose of one tablet , tell your doctor or nurse as soon as possible . if it
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people ) bleeding in general bleeding including the nose bleeding from the brain bleeding from inside the gut vomiting blood bleeding from around the lungs bleeding from blood in the urine and in the mouth bleeding from under the skin coagulopathy ( disturbance of blood clotting ) nausea vomiting diarrhoea rash itching fever uncommon (
keep out of the reach and sight of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use definitelio if you notice that the solution is cloudy or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains the active substance is defibrotide . each 2 . 5 ml vial contains 200 mg of defibroide . after dilution , each ml solution contains 80 mg of the active ingredient in defibrielio . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections . what defitelsio looks like and contents of the pack defiteloio is a clear , colourless to pale yellow solution for infusion . it is supplied in a 10 ml glass vial with 2 . 05 ml
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c , an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by stopping the hepatitisc virus from multiplying in your body . it reduces the amount of hepatitis cirus in your blood . daklinz is used in combination with other medicines to treat other types of hepatitisc infection . your doctor will discuss with you which combination of the other medicines with daklanza is best for you . if you have any questions about your medicines , please ask your doctor .
do not take daklinza - if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) - if your child is taking any medicines containing phenytoin ( e . g . carbamazepine , oxcarbazepine or phenobarbital used to treat epileptic seizures ) - rifampicin , rifabutin and rifapentine ( antibiotics used to prevent tuberculosis ) - dexamethasone ( a steroid used to correct allergic and inflammatory diseases ) - medicines containing st . john ' s wort (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . do not take more than this dose once a week . do this twice a day to avoid unpleasant taste . daklanza may be taken with some other medicines . if you take more daklineza than you should if you have taken more dailinza than your doctor tells you to , talk to your doctor . if possible , take these medicines with a meal . your doctor may increase your daily dose of taklin
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza in combination with sofosbuvir and ribavirin has been associated with the following side effects : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when taking daklineza in tandem with sofuosbuir and ribvirin , the following other side effects have been associated : common ( likely to affect up in every
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate , hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) 51 what daklineza looks like and contents of the pack 30
proquad is a vaccine to protect against measles , mumps , rubella , chickenpox ( varicella ) viruses . when a person is given the vaccine , the body ' s natural defences ( antibodies ) will produce its own protection ( antibodies ). this protects against the measles , rubles , mocks , ruble and varicelluses . when the antibodies produce protection against diseases caused by these viruses , proquad can be given to individuals from 9 years of age and older . national vaccination schedules are available to protect you against measles caused by live viruses , which can cause measles , measles , , rubello , chicken
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have a blood disorder or type of cancer that affects the immune system ( including treatment with medications that suppress the immunesystem ), if you receive low - dose corticosteroid therapy ( for asthma or replacement therapy ), if your doctor has told you that you have developed a weakened immune system , if you suffer from a disease ( including aids ), if congenital or hereditary immunodeficiency ( immune competence ), if active untreated
proquad is given by injection into a muscle ( subcutaneous injection ) under the skin ( usually in the thigh or upper arm ). injections should not be injected into the muscle ( usually into the thigh area or upper upper arm ) unless the doctor has told you to . if you have a blood clotting disorder or low levels of platelets , the vaccine should not go under the sunbed or under the cover of a hospital bed . bleeding may occur in the muscle . proquad should not enter into a blood vessel . prorant should not come into contact with blood . the vaccine must be injected under the same skin as in normal
like all vaccines , medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives may occur . if these reactions occur , you may experience difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad are : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) and a fever . rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). other side side effects reported with the use of proquad include
what proquad contains the active substances are : measles virus1 , edmonston strain ( equivalent to 3 . 00 mg mumps virus1 ) jeryllynn™ ( level b ) strain ( corresponding to 4 . 30 mg rubella virus2 , strain (ivalent to 3. 00 mg varicella virus3 ) merck strain ( approximate 3 . 99 mg mrc ). the other ingredients are : tissue culture : plaque - forming units ( eps ), 1 type of chickembryo cells ( fibroblasts ), mrc , powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbit
jylamvo is a substance that is absorbed into the body and is an anticancer medicine which reduces unwanted reactions . it is an immunosuppressive agent . by reducing the inflammatory effect jylamo is used to treat rheumatic and skin diseases : - active rheumatoid arthritis ( with polyarthritic forms in the joints ) - severe juvenile idiopathic arthritis ( jia ) in children and adolescents 3 years of age and older . it may be used alone or in combination with non - steroidal anti - inflammatory drugs ( nsaids ) to treat inadequate o severe or disabling psoriasis in
do not use jylamvo - if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you have a severe kidney impairment - if the doctor has prescribed jylimvo - you have ever had a liver impairment - you suffer from blood disorders such as bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia 34 - you are suffering from a weakened immune system - you know that you are at risk of developing a serious infection such as tuberculosis or hiv - you develop
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . your doctor will discuss these with you and will adjust the dose and duration of the treatment . rheumatoid arthritis severe juvenile idiopathic arthritis severe psoriasis if you have severe psoriatic arthritis , jylimvo is used as a long - term treatment . jyslamvo should be used for rheumatic and skin diseases such as jia , psorism or psoriatics arthritis . your
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching , especially affecting your whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort severe diarrhoea mouth ulcers , black or tarry
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . store in the original package in order to protect from light . the medicine should be used immediately in case of accidental spillage . the vial can be stored for up to 3 days at 2ºc - 8ºc . do away with any unused medicine or waste material . this includes any unused product or waste materials . these measures will help protect the environment .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotroxybenzoate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzzoate ( e218 ), sodium methyl parahhydroxybenziate (e218 ), citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl paraahydrobenzoates and sodium methyl paraahhydxybenzoATE "). what jyamel
this medicine contains the active substance glycopyrronium bromide , which belongs to a group of medicines called bronchodilators . this medicine is used to make breathing easier for adult patients who have breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten , making breathing difficult . this medication prevents tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine on the everyday life of copd .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if the doctor has prescribed enurezhalhaler for you . - tell your doctor if you have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). your doctor will decide whether treatment with enurell breez inhaler is appropriate for you and will decide if you should discontinue using this medicine . warnings and precautions talk to your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhaler twice a day . you should use this this medicine for 24 hours at the same time each day . your doctor will tell you how many capsules to use . the recommended starting dose is 75 mg twice a week . you can use this medicinal for as long as your prescribed dose . how to use this product this medicine comes as an inhaler and capsules ( in blisters ). the medicine is inhaled using inhalation powder . the capsules should be inhaled
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious : common ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms are excessive thirst , hunger ( frequent urination ), rash , itching , hives , difficulty breathing or swallowing , dizziness . allergic reaction ( swelling mainly of the tongue , lips , face or throat ) angioedema ( see section 2 ). other side effects include some side effect ( frequency cannot be estimated from the available data ) common side effects ( may effect up to1
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyroniumbromide equivalent to 50 microgram of glycopirronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram glycopyrsronium per inhalation dose . - the other ingredients are lactose monohydrate and magnesium stearate . what enurevo breez inhaler looks like and contents of the pack enurevan breezer 44 microlitre inhalation powder is
riximyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in the body called " b - lymphocyte ". when ritukimab sticks to the target , it stops the growth of the cells and kills them . how riximyo works riximusyo is used for the treatment of two different conditions : a ) non - hodgkin ' s lymphoma this is an illness of the lymph tissue . the immune system ( the body ' s natural defences ) destroys a type a white blood cell called
do not use riximyo if you are allergic to rituximab , other proteins that are similar to ritonuximib or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor thinks that you have severe heart failure or severe uncontrolled heart disease . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before using riximusyo if : you have ever had granulomatosis , polyangiitis , microscopic polyangitis
your doctor will decide how much riximyo you will receive and how often you will need this treatment . your doctor will check whether you are having this medicine and if you are experiencing any side effects . riximeyo is given as a drip ( intra - venous infusion ). medicines given before each riximusyo administration you will be given rixamyo together with other medicines ( premedication ) to reduce the risk of side effects during your treatment . if you have non - hodgkin ' s lymphoma , you will usually receive rixima alone rixmeyo once every 4 weeks . repeated
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and will generally disappear after a few days of treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills or shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / ml ). each 50 ml vials contain 500 mg of the active ingredient in ritiximab , 10 mg per ml . the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide and hydrochloric acid ( see section 2 " rixamyo contains sodium "). what rixima looks like and contents of the pack riximusyo is a clear , colourless to slightly yellowish solution for
topotecan actavis contains the active substance topotecin . topotecaan activ is used to treat small cell lung cancer that has come back after chemotherapy or has advanced cervical cancer that cannot be treated with surgery or radiotherapy . in this case topotan actv treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using topotocan activ . your doctor may check your blood cell counts if they are too low . your dose of topotican actv may need to be adjusted . - if your doctor has told you that you have any kidney problems . your treatment with topotchean actav may need adjusting . warnings and risks talk to the doctor or nurse before using this medicine : - if any
your doctor will determine the dose of topotecan actavis you will receive and will determine how often you will be given it . the doctor will also check the disease and your response to blood tests during treatment . the usual dose for treatment of adults small cell lung cancer is 1 . 5 mg per square metre of body surface area for every square metre you weigh , for every 5 square metre that you weigh . this treatment cycle will also include cervical cancer . the recommended dose is 0 . 75 mg per sq metre of surface area , for each square metre which you weigh on average , for the first 3 weeks of this treatmentcycle .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects serious side side effects including infections may occur very commonly ( may affect more than 1 in 10 people ) and may be serious . tell your doctor immediately if you experience : fever , your general condition ( local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea , or bowel inflammation ) has been reported rarely ( may be fatal ) in patients with neutropenic colitis . your doctor may stop topotecan actavis temporarily or permanently , or temporarily , temporarily , reducing your ability to fight infections
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . keep the vials in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 and 2 to 8 oc . from a microbiological point of view , the product should be used immediately . if not used immediately , in - used storage times and conditions prior to use are
what topotecan actavis contains the active substance is topotan . 1 mg / 4 mg : each vial contains topotecaan ( as hydrochloride ). after reconstitution 1 ml contains 1 mg of topotican . the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotnican actis looks like and contents of the pack topottecan actalis is a white to off - white cake with grey bromobutylic stopper and aluminium seals with plastic flip - off caps and a protective
the active substance of rivastigmine hexal is rivustigmine . rivestigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivaldigmine works by blocking the enzymes that break down acetylCHoline : acetylchlorolinescerase and butyrylcholinesternase . by
do not take rivastigmine hexal - if you are allergic to rivasta , the active substance in rivostigminehexal , or any of the other ingredients of this medicine ( listed in section 6 ). - if a previous skin reaction ( allergic contact dermatitis ) has been severe . warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking the medicine . warnings , precautions and precautions tell your physician before taking : - if your child has irregular or slow heartbeat - if he / she has an
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be increased to 6 . 0 mg once a day . your doctor may also increase your dose depending on your weight . your dose will depend on your general condition and overall health . taking this medicine take rivasta hexal every day for as long as your health allows . if you have not taken
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects listed below have been observed with rivastigmine hexal : very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ): anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what rivastigmine hexal contains 64 the active substance is rivastaigmine hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivastsigminehexal 1 . 5 mg capsule contains 1 . 25 mg of rivostigmine . each vial of each rrivastigine hexal 3 mg capsule releases 3 mg of the active ingredient rivasigmine (
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with kidney cancer ( renal cell carcinoma ) or liver cancer that has come back after receiving a specific anticancer medicine containing sorafenib . how cabometyx works cabometx blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . by blocking these proteins , cabomety can block the action and spread of high amounts in cancer cells . this will help to stop cabometometyx from working .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety - if your doctor has told you that you have high blood pressure - if the patient has an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall - if this has happened to you - if he or she has diarrhoea - if any of these apply to you ( or you are not sure ), talk to the doctor or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take this tablet at the same time each day . your doctor may increase your dose or stop your treatment if you experience serious side effects . your treatment with cabometyx will usually be started by a doctor who is experienced in the treatment of patients with dementia . the usual starting dose of cabometx is 60 mg once a day , taken once a morning . you can take cabometometyx with or without food , for 2 hours at a time .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines : tell your doctor straight away if your side effects become severe or persistent . tell your healthcare professional straight away : if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea ), vomiting , constipation , fever , and a gastrointestinal perforation ( a hole that develops in the stomach or intestine ) which may lead to severe or uncontrollable bleeding . symptoms include vomiting blood , black stolls , bloody urine , headache ,
what cabometyx contains - the active substances are cabozantinib and malate . cabomety 20 mg film - coated tablets : each tablet contains cabozatinib ( s ) and malates . each tablet provides 20 mg cabozinib . cabobometyx 40 mg film coated tablets: each tablet contain cabozutinib_( s ) or malate and provide 40 mg caboxantinab . cabibometyx 60 mg film coating tablets : all tablet strengths contain cab ozantinip ( s ), malate , and provide 60 mg caboyantinub . - the other
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemrexed hospira will also be given in combination to cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will determine whether pemetreed hospir is suitable for you if you have lung cancer at an
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has decided that you should stop breast - feeding during treatment with pemetemetrexED hospira . - if any of these applies to you , tell your doctor . - you have recently received or might receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetezed hospir if you have or have had problems with your kidneys . before you receive pemeted hospiar
the dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out your dose based on this body surface area and will adjust the dose and frequency of treatment depending on your blood cell counts . your healthcare professional will have mixed the pemetreed hospir powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . pemetemetrexED hospira will be given to your doctor by infusion into one of your veins .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38ºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( uncommon ). if you develop pain , redness , swelling or sores in your mouth ( very common ) allergic reaction : if you notice skin rash ( common ),
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc . the reconstuted solution should be administered immediately . parenteral medicines
what pemetrexed hospira contains the active substance is pemetre . pemetrion hospira 100 mg : each vial contains 100 mg of pemetereed ( as pemetretrexed disodium hemipentahydrate ). pemetrxed hospir 500 mg : one vial of 500 mg of dispemetrexED ( as dispemetreted dis sodium hemipertahydrates ). pemrexedospira 1 , 000 mg : the active ingredient is petrexed . after reconstitution , the solution contains 25 mg / ml of pemphrexed (
ganfort contains two active substances called bimatoprost and timolol which work together to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which act together to form a prostaglandin analogue . timolole belongs to medicines called beta - blockers . ganfort is used to lower pressure in your eye . it is used in adults , adolescents and children aged one month and older . gansfort is for use in the adult eye . ganedfort is a clear , watery liquid that is injected into the eye to help lower pressure . it
do not use ganfort eye drops : if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) if you have respiratory problems such as asthma or severe chronic obstructive bronchitis if you suffer from severe lung disease ( signs include wheeziness , difficulty in breathing , or long - standing cough ) if any of these apply to you , tell your doctor before using ganst . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : have coronary heart disease ( symptoms include chest pain ,
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use genfort is for oral use . it is for use by adults only . use in children and adolescents the recommended dose is one drop in the eye once a day . for treatment , the bottle should be opened and the tip of the bottle inserted into your neck should be gently swirled until the tip is firmly closed . step 5 . gently shake your hands . tilt your head back . step 2 . pull down your eyelid , which is hidden in a small pocket . step 3 .
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause the following side effects when used with ganart ( multi - dose or single - dose ). very common side effects ( may affect more than 1 in 10 people ) the eye redness . common side effect ( may affects up to 1 in 9 people ) 100 the eye burning , itching , stinging or irritation of the conjunctiva ( the transparent layer at the back of the eye which lines the front of the lens and reduces sensitivity to light ). eye pain , sticky eyes , dry eyes , feeling of something in the
keep this medicine out of the sight and reach of children . do not use solutions that are not clear and colourless . this will help protect the environment . ganfort will be used immediately after opening . if you notice any visible signs of eye infections , immediately contact your doctor . the solution should be used within 4 hours . do this immediately if you noticed any change in the appearance of the solution . do so if you observe any change to the appearance or the appearance , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / 0 . 5 ml ) timolol ( 5 mg / ml ) and timolole maleate ( 6 . 8 mg / 1 ml ). - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack gan fort is a clear to slightly yellow , colourless to pale yellow eye
gefitinib mylan contains the active substance gefitinib . this protein is designed to recognise and kill cancer cells . gefitoninib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefnitinibmylan if : you have any other lung problems . some lung problems may get worse while taking gekitininib melan . you have problems with your liver . gefinib is not recommended for use in children under 18 years of age . other medicines and gefitalinib tell your doctor if you take , have recently taken or might take any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet of antacids taken once a day on an empty stomach ( see section 2 , " gefitinib mylan contains lactose "). take gefnitinib melan at about the same time each day . if you have trouble swallowing the tablet , you can take it with or without food . do not split , crush or split the tablet . if your doctor recommends that you take any other liquids , drink them immediately . the maximum recommended dose for
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions affecting your body . the signs may
what gefitinib mylan contains - the active substance is gefetinib . each film - coated tablet contains 250 mg of gefinib - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide red ( e 172 ). what gefitoninib melan
reblozyl contains the active substance luspatercept which is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms can lead to a low red blood cell count ( anaemia ) and need red blood infusion . reblozey is used : to treat anaemia in patients with mds who cannot receive red blood stem cell transplants ( erythropoietin therapies ) in patients who have beta - thalassaemia . thalAssaemia is a
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant ( see pregnancy section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have thalassaemia ( a condition where a spleen removed ) or have had a blood clot . your doctor may decide to restart hormone replacement therapy if you had a previous blood clot and you are not taking preventive measures against medicines that prevent a blood clot . if you suffer from high blood pressure , your doctor will monitor your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you are given reblozyl . rebl ozyl is given as an injection under the skin . the dose is based on how much you weigh . the injections should be given every two weeks . the recommended dose is 1 . 0 mg / kg of body weight . your dose may be adjusted by your doctor depending on your blood pressure . use in children and adolescents reblzyl is not recommended for use in patients with myelodysplastic syndrom
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you have : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions with rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . very common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 25 days or at room temperatures ( up up to 24 ) for a maximum period of 2 weeks . do away with any unused medicinal product or waste material . ask your pharmacist how to throw away medicines you no longer use .
what reblozyl contains - the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspaterscept . after reconstitution , each mlof solution contains 50 mg of the active ingredient luspatingcept . - the other excipients are citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pct adjustment ). what rebl ozyl looks like and contents of the pack reblizyl is a white to off - white powder . rebloxyl is supplied in v
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tiv ozanib works by stopping the growth of the cancer by stopping cancer cells from multiplying and forming new blood vessels . fotivd is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to control your disease or have not worked well enough .
do not take fotivda - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor before taking fotiveda . high blood pressure the dose of fotiva depends on your blood pressure . your doctor will check your blood blood pressure regularly while you are taking a medicine . fotivoda may lower your bloodpressure if you take foveivda , or if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg once a day ( 21 days ) taken orally with or without food . this means that you take 7 capsules once a morning ( 7 days ) with or with food . you take 1 capsule once a afternoon ( 4 days ) of futivda . if you take more fotvda than you should if you have taken too many capsules , you may experience unacceptable side effects . severe side effects may occur during fotvelda therapy . the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). tell your doctor immediately if you experience any of the following : high blood hypertension with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may want to monitor your blood pressure more closely while you are taking fotivda . high bloodpressure is often treated with a medicine to treat your high blood blood pressure . if you take more f
what fotivda contains the active substance of fotive is tivozanib . each tablet contains 890 mg of tiv ozanib ( as tivzanib hydrochloride monohydrate ). the other ingredients are : capsule content : 890mg tivuzanib , mannitol ( e421 ), magnesium stearate capsule shell : gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( for strong ammonia solution ), titanium dioxide , tartrazine aluminium lake ( e133 ) and shellac ( e
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of the human immune system . elvitabine , an antiiretrolimiral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ). tenofovir disoproxil , an antitroviral medication called a nucleotide reverse transcriptases inhibitor ( rtti ). stribild is used as a single tablet regimen for the treatment of human immunodeficiency virus
do not take stribild - if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). during treatment , you should not take any medicine containing tenofovegravira disoprocessil . your doctor will monitor your kidney function and may change your dose of these medicines . - if your doctor has told you that you have alfuzosin ( an enlarged prostate gland ), amiodarone , quinidine
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age : the recommended dose is 35 mg taken by mouth once a day . you should take your medicine at the same time each day . your doctor may change the dose or stop the treatment if you take medicines ( oral supplements , antacids , laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ) for at least 4 weeks . if you forget to take stribild if you miss a dose , take it as soon as you
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is very important to avoid unwanted effects . stribild does not cure the hick disease itself . serious side effects tell your doctor immediately lactic acidosis ( excess lacticacid in the blood ) is a common side effect of
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtracitabINE , 245 mg tenofnovir disopicroxil and 300 mg ten ofovir dissoproxel fumarate , each 136 mg tablet contains tenofovegravin . the other ingredients are : tablet core : croscarmellose sodium , hydroxypropyl
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zypxa . zypitxa is not recommended for elderly patients with dementia as it may have serious side effects .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets are for oral use . swallow the tablets whole with a glass of water . z yprexa can be taken with or without food . you can take the tablets with or just after food . the usual dose is one 5 mg tablet once a day . your doctor may increase your dose to one 20 mg tablet twice a day depending on your symptoms . swallow your tablet whole with water . do not chew or crush the tablet . zzyprexa should be taken orally with or shortly after
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( a rare side effect which may affect upto 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing , sweating
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this to avoid damage to the hard capsules . zyprexa must not be re - used if you notice any visible signs of tampering . do ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zyprixa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg of olanza . the other ingredients are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypyxa tablet strengths are marked with the following symbols : - zypoxa 2 . 4 mg , 6 mg , 7
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein that is produced naturally in the body . it is used to prevent bone loss in adult patients with osteoporosis when treatment is not suitable . prolia helps to make bone stronger and keeps it free of oestrogen . it reduces the amount of oesterrogen that can build up in bones after the menopause . when oestrogens level drops , bones become thin and fragile . what osteopORosis is osteoporeosis is caused by the lack of testosterone produced by the body
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think any of these apply to you , tell your doctor before using this medicine . if any of them apply to your child , tell the doctor before starting prolia , as prolia may cause a skin infection . symptoms may include a swollen , red area of skin , usually in the leg , which feels hot and tender . if
always use prolia exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one pre - filled syringe of 60 ml for adults and children aged 6 months and above . it is given as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . you can inject prolia yourself or with a caregiver . you should wear stickers to help protect your skin . if you use more prolia than you should if you have accidentally injected too much prolia , talk to your doctor . you may require calcium and
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and tell your doctor straight away if you develop skin infections ( cellulitis ). if you have any of these symptoms while taking prolause : swollen , red area of skin , usually in the leg , which feels hot and tender . if you get symptoms such as fever , stop taking the medicine and contact your doctor immediately . if any of the symptoms get serious , stop using prolia . pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be stored at room temperature ( up to 25 ) for a single period of maximum three months . after the injection , it may be kept at room temperatures ( up or down ) for no longer than 25 days or at room room
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg of denosumaab , corresponding to 60 mg / ml . - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirrix is a vaccine used to protect adults , adolescents and children from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b . infection with the hepatitis a virus causes the liver to become swollen and inflamed . the virus can also cause the virus to infect faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . you may feel sick , have a fever , aches , pains , feel very tired , dark urine , pale faecES , yellowish skin or eyes ( jaundice ). the severity and type of symptoms vary from person to person
you must not be given ambirix if you are allergic to ambirax or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . signs of such an allergic response may occur with any vaccine . if you have hepatitis a or hepatitis b diseases , you have a severe infection with a high temperature . the vaccine should be given at the same time as a minor infection such as a cold . warnings and precautions talk to your doctor or nurse before you are given ambiraix . ambirux should
your doctor or nurse will give you ambirix as an injection into a muscle ( usually in the upper arm ). ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be repeated within 12 months . you may receive a second injection at least 6 and 12 months after the first injection . you should not receive extra doses to make up for future booster dosing . if you miss two injections , tell your doctor or get another appointment . if the diseases return after the second injection , you should contact your doctor .
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : very common ( may affect more than 1 in 10 people ): headache loss of appetite feeling tired or irritable pain or redness
what ambirix contains 26 the active substances are hepatitis a virus ( 1 , 720 micrograms / ml ) and elisa units ( hepatitis b surface antigen ). the other ingredients are : 20 microgram ( 0 . 5 milligrams ) human diploid ( mrc ), cells , aluminium hydroxide , hydrated 0 . 05 milligram ( 0. 05 millilitre ) saccharomyces cerevisiae , aluminium phosphate , 0 . 4 milliggram ( millilitres ) sodium chloride and water for injections what ambirax looks like and contents of the pack suspension for injection in a pre -
what bexsero is bex sero is a meningococcal group b vaccine . what bexero is used for bex serumo is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria are very sensitive to infections ( such as meningitis , inflammation of the brain and spinal cord ) and can cause sepsis ( blood poisoning ). the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease .
do not use bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using bex serumo if : you have a severe infection with a high temperature ( over 38 ). vaccination should be postponed until you have recovered from a minor infection such as a cold . vaccination should not be given if you have haemophilia a or any other problem that may prevent your blood from clotting properly . you are taking blood thinners ( anticoagulants ) as part of treatment for the immune system ( eculizumab
your doctor or nurse will give you bexsero at a dose of 5 micrograms per injection into the muscle of the thigh or upper arm . injections will be given every 2 weeks from the second week up to the third week up until the third year up to a dose ranging from 5 microg . three injections will give the vaccine . your doctor will decide whether you need an additional injection ( booster ). the first injection will be administered at 2 - 3 weeks intervals . the interval between injections will usually be 1 month . your physician will decide if you need the booster . children and adolescents from 2 months of age onwards , the
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the injected site , hardness of the surface of the injected area . other side effects may occur with this vaccine . common ( might affect up to 1 in every 10 people ) fever , loss of appetite , tenderness around the injectionsite , severe injection site tender
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 50 micrograms recombinant nisseria maningitis group b novadine protein 1 and 2 , each containing 50 micrograms recombinant neoisseria meingitidas group b fhbp fusion protein 3 and 3 50 iu recombinant novadsorbed on neissia meningitsidis group a fhba infusion protein 1, 2 , and 3 containing 50 igrams the active substance is produced by recombinant dna
nitisinone mdk contains the active substance nitisinon . this medicine is used to treat a rare disease called hereditary tyrosinemia ( haematocrit ). in people with this disease your body does not make enough of the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). nitisinnone helps to reduce the amount of tyrosino and the harmful substances that can occur after taking this medicine . tyrosrine is a substance that is naturally present on the surface of the body . low tyrosinine can replace phenylalanine ( another amino acid ).
do not take nitisinone mdk if you are allergic to nitisine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding if you have been told by your doctor that you have an increased risk of developing an infection of your eyes during nitisatinone treatment , you should immediately have an eye examination . if you develop red eyes , you must immediately have your eyes examined . if possible , you may be given an eye test . if any of these apply to you , tell your doctor . if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment should be started as soon as possible after the first dose of this medicine , depending on the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule for every kg of body weight taken orally once a day . the dose may be increased to 20 capsules once a daily . in this patient population , the recommended starting dose is one capsule for each kg of weight taken once a morning . swallow the capsules whole with a small amount of water or formula diet . if you take more nitis
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 2 8 . do away with the blister once you have reached a temperature not above 25 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains the active substance is nitisino . nitishinone mdky 2 mg : each hard capsule contains 2 mg nitisine . nisinone dk 5 mg : one hard capsule each contains 5 mg nisine . each hard capsules of nitisrinone mdks 10 mg : two hard capsules each contain 10 mg nitesinone . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), and shellac glaze . what nitisinnone mdK looks like and contents of the pack nitisinsone md k capsules
what docetaxel accord is docetayel accord contains the active substance docetxel . docetel accord belongs to the group of anti - cancer medicines called taxoids . doceteaxel accord is used to treat breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : in adults with advanced breast cancer the combination of docetailel , doxorubicin , trastuzumab or capecitabine is used for early breast cancer with or without lymph node involvement . in combination with docetamide
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) - if white blood cells are low - if your liver is not working properly - if there is a severe liver disease warnings and precautions before you are given docetel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacord . in case of white blood cell disturbances , you may experience fever and infections . tell your doctor immediately if you have abdominal pain , tenderness
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m² ) and will calculate the dose you should receive . method and route of administration docetaxal accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . your healthcare professional will take a number of different actions , including : - depending on the results of your blood tests and
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells ( alopecia ), nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of doceteaxel alone may be increased when docetxel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions ( very common , may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store below 25 . do away with the vial . after dilution , the medicine should be transferred from the infusion bag to the infusion vial and stored at room temperature ( up to 6 ) for up to 25 days . for infusion , the infusion solution should be used immediately . non - pvc bags may be stored for 48 hours at 2 to 8 . do this to protect from light .
what docetaxel accord contains - the active substance is docetxel . each ml of concentrate for solution for infusion contains 20 mg docetel . 1 vial of concentrate contains 20mg docetixel . 4 vials of concentrate contain 80 mg docel . 8 vials ( 0 . 8 ml ) of concentrate concentrate contains 160 mg docnetaxel . - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetacord contains ethanol an hydrous "), citric acid anhydrated ( see " docel accord contain ethanol anhrous ").
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the electrical activity of the brain . this medicinal product works by reducing the actions of impulsive or hyperactive individuals . this medication is used to treat ' attention deficiency hyperactivity disorder ' in adults with adhd when current stimulant medication is not controlling adhd symptoms . the medicine is used in combination with a treatment programme consisting of psychological therapy , educational therapy and social therapy . intuniv is used 38 to treat adults with a diagnosis of adhd . it is used when adhd is not controlled by other treatments . it
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking intunive if you have low or high blood pressure , heart problems or heart problems . tell your doctor if you fainted recently or have thoughts or feelings of suicide . tell the doctor if any of these apply to you . if you suffer from any other psychiatric conditions , including withdrawal symptoms , increased heart rate , high bloodpressure , or any other conditions that increase the amount of this medication you take . this medicine should be
your treatment should be initiated under the supervision of a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will determine the dose that is right for you . your treatment will be started with 1 tablet once daily . the dose will be gradually increased depending on how you respond to treatment . the starting dose is 0 . 05 mg / kg bodyweight once daily ( for example , 0 . 12 mg / m2 bodyweight ). your doctor may increase your dose
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , talk to your doctor or pharmacist straight away . your doctor may need to change your medicine . serious side effects tell your doctor straight away if you notice any of the following serious side effect : feeling drowsy ( feeling dizzy ), hypotension ( slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect from high blood pressure . symptoms may include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). tell your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within one month of first opening the blister pack . do away with the blister after this period . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg of guanFacine . each 2 mg prolonged -release tablet contains guanfuine . the 3 mg prolonged prolonged - releases tablet contains 3 mg of Guanfacin . each 4 mg prolonged release tablet delivers guanfa hydrochlorine . what intunive looks like and contents of the pack intuniva is a white to off - white , round tablet with " gsi " debossed on one side and " gs " debottled on the other side . the tablet core
ecalta contains the active substance anidulafungin and is used to treat adults and children from 1 to 18 years old with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida that are cut or chewed by echinocandins . these medicines prevent serious fungal infections from spreading and destroy fungal cell walls . ecalta works by preventing the formation of new cells . this can help to protect your body from the infection . it also prevents fungal types called candidas from growing and destroying echinOC
do not use ecalta - if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecalten . if you have liver function problems , your doctor may decide to delay your treatment with anaesthetics . during your treatment , your dose of ecaltene may be reduced . if an allergic reaction occurs , you may experience itching , wheezing , blotchy skin . an infusion related reaction may include a rash , h
the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg or 100 mg given once a day . adults ( aged 1 to 18 years ) the recommended starting dose is 3 . 0 mg . this dose may be increased to 200 mg , 1 . 5 mg or to 100 mg depending on the patient ' s weight . ecalta is given as a slow infusion ( a drip into a vein ) lasting 1 . 4 to 3 hours . the loading dose will be adjusted by your doctor depending on how well the infusion is working and on thepatient ' sweight . duration of your treatment your doctor will
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta can cause serious sideeffects , including convulsion ( seizure ), flushing , rash , pruritis ( itching ), hot flush , hives , sudden contraction of the muscles , wheezezing , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): low blood potassium ( hypokalaemia ), diarrhoea
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 . if the infusion solution is not used within 24 hours , in use immediately , the infusion solutions may
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anidulinafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid 30 . what ecaltas looks like and contents of the pack ecaltta is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( hcviii ). factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is missing or not working properly . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older with haemaophilia b , an inherited bleeding disorder caused by lack of factor v ii .
do not use adynovi - if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is allergic to any of these ingredients . warnings and precautions talk to your doctor or pharmacist before using adynov : - if the child has had an anaphylactic reaction ( a severe , sudden allergic reaction to any ingredient of adyno ). allergic reactions may include rash , 95 hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheez
treatment with adynovi will be started by a doctor with experience in the treatment of haemophilia a . always use adynovovi exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment of bleeding your doctor will decide whether adynova is suitable for you . the replacement therapy with adnovi is a life - long treatment . always take this medicine exactly as described in this leaflet and as long as your healthcare professional tells you . if you have any further questions on the use of this medicine , ask your doctor . prevention of bleeding the recommended dose of ad
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur within minutes of the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , general feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath , wheeezing or tightness around the chest ( general feelingof being un unwell ), dizziness or loss of awareness , contact your doctor immediately .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a single period of up to 3 months . this medicine may be kept at room temperatures ( up or down ) for up to a maximum of 3 months and must be discarded if not
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu of ruricoctocag alfa pepegol . the solvent vial is provided with 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane
rekovelle contains follitropin delta , a follicle stimulating hormone that belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection ). they are produced by the ovaries of women who have not ovulated and produce many egg sacs .
do not use this medicine if you are suffering from your fertility problems , if you think you may be allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus if you know that you have enlarged ovaries or cysts on your ovaries if you suffer from polycystic ovarian disease ( bleeding from the vagina ) if your partner has an early menopause if you had malformations of the sexual organs ( which may or may not have been caused by pregnancy ) if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given as your first treatment cycle . your doctor will prescribe anti - Müllerian hormone to stimulate your ovaries to produce more stimulation with gonadotropins . the dose will depend on your blood weight . your dose will also be calculated from a blood sample taken every 12 months . the duration of treatment depends on your body weight . the first dose of treatment will be administered as your second dose . the second dose of the recovelledose will be taken as
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that are used to treat infertility have been reported in women taking this medicine . there may be a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen . nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you experience any of these symptoms , seek medical advice immediately . a side effect that may affect up to 1 in 10 women is headache . nausea ( ovarianhyperstimulation sensation ) pelvic pain and discomfort ( ovarian origin tired
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . after reconstitution , the product may be stored for up to 3 days at room temperature ( up to 28 ) or below 25 for up up to a maximum of one year . after the treatment any unused solution must be discarded . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after reconstitution , each ml of solution contains 33 . 3 mg of of folliotropin delta in each millilitere of solution ( corresponding to 0 . 35 ml of the solution ). - the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrine , concentrated phosphoric acid , sodium hydrox
the active substances of revinty ellipta are fluticasone furoate and vilanterol . revintchy ellipta contains two active substances : flutic asone fureate 92 mg and vilterol 22 mg . each inhalation contains either fluticasa furoATE 184 mg or vilancerol 22 / 22 mg in each inhaler . chronic obstructive pulmonary disease ( copd ) asthma is a group of conditions that affect breathing problems and other symptoms of copd . asthma is the most common symptom of asthma in adults . it is usually associated with a sudden attack of breathlessness or
do not use ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using ellipta . ellipta should not be used if you have liver disease , as it may cause side effects . if you suffer from moderate or severe liver disease the lower strength of revinty ellipta 92 / 22 mg should be used instead of 92 / 23 mg . talk to a doctor or nurse before using this medicine if you : - have heart problems - have high blood pressure
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use asthma the recommended dose for asthma is one inhalation twice a day ( one inhaler of fluticasone furoate and 22 mg vilanterol ) once a day . for severe asthma , your doctor may prescribe the higher strength inhaler ( fluticasa furoATE and 22mg vilansterol ) twice a week . copd the recommended starting dose for copd is one and a half inhalations ( one and two inhalations of flilitasonef
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta may occur rarely ( may affect up to 1 in 1 , 000 people ). if you have any of the following symptoms while taking ellipta : stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , especially of the face or mouth ( angioedema ) feeling very wheezy or coughing , having difficulty in breathing , feeling weak or light headed ( collapse or loss of consciousness ) immediate breathing difficulties if you experience immediate breathing difficulty while taking revinty ellipta ,
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each inhalation provides 92 doses ( the dose leaving the mouthpiece ) of 92 micrograms of flutic asone fureate and 22 microgram of vilancerol ( as trifenatate ). each 184 microgram inhalation delivers 184 doses ( as fluticASone furyate and 222 microgram s of vilterol (as trifnatate )). the other ingredients are lactose monohydrate ( see section 2 " revintchy ellipta is a powder
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosiderase reverse transcript enzyme inhibitor ( tnrtis ), tenofovir , a nucleotide reverse transcriptases inhibitor (nnrtti ). these active substances are all given to you by your doctor together with antiretroviral medicines . they work by interfering with the normal working of an enzyme ( reverse transcriptasing ) that is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects such as dizziness and drowsiness have been reported . if you take more atripola than you should if you accidentally take too many atriblea tablets , contact your doctor immediately . if possible , show the doctor your pack of tablets . if necessary , show them the pack of atrilea
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and contact your doctor immediately :
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atriblea film - coated tablet contains 600 mg efavenirenz and 200 mg emtritabine , respectively 245 mg tenofvir disopicroxil ( as fumarate ). the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atriplea contains sodium "). the tablet film coating
orgalutran contains the active substance ganirelix . it belongs to a class of medicines called anti - gonadotrophin . it is a synthetic version of the natural gonadodotrophins releasing hormone ( gnrh ) that is produced by the body . when the natural gnrh regulates the release of gonadotropins , follicle stimulating hormone ( fsh ) is released . gonadrophins play an important role in the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells straight away . they
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - if your body is hypersensitive to gonadotrophin releasing hormone ( gnrh ) or a gnrh analogue . - if the patient has a moderate or severe kidney or liver disease . - do not become pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions may be signs of an active allergic condition . your doctor will do additional monitoring during treatment . allergic reactions if you have allergic reactions ( generalised , e
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran must only be used by a doctor who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( corifollitropin ), on day 2 or day 3 of each cycle . orgdalutran is injected under the skin ( subcutaneously ) on day 5 and 6 of each cycles . orglutran can be used either alone or in combination with fsh . the preparations are
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people is local skin reactions ( redness and swelling ). the local reaction usually disappears after a few days . see section 4 for more information . uncommon ( may affect up to 1 in 100 people ) is headache , nausea , malaise . rare ( may affects up to1 in 10 , 000 people ) are allergic reactions ( rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat , difficulty in breathing or swallowing ( angio
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe after exp . the exp date refers to the last day of that month . syringes should be clear , colour - free solutions . do this to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix 0 . 5 mg / ml . - the other ingredients are acetic acid , mannitol , water for injections ( for the ph ), sodium hydroxide and acetic acids . what orgaluitran looks like and contents of the pack orgaluchran is a clear , colourless aqueous solution for injection . the solution is clear and colourless . it is for subcutaneous administration . the needle is inserted into a dry natural rubber / latex . orgalustran is available in packs containing 1 or 5 vials . not
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type in the body called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target of this target , the cell dies . what blitzima used for blitzima can be used in adults with : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue . the immune system ( the body ' s natural defences ) can destroy a type a of
do not use blitzima if you are allergic to rituximab , other proteins that are similar to ritonuximb or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor or pharmacist before using blitzima : if you currently have granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris . warnings , precautions and precautions
how blitzima is given your doctor will decide how much blitzima you need and how often you need to have this treatment . your doctor may decide to stop you using this medicine if you have any side effects . how blitzima will be given blitzima comes as a drip ( intravenous infusion ). it is given to you by a doctor or nurse who is experienced in the use of medicines similar to that given by your doctor . each blitzima administration will be overseen by a healthcare professional . your dose of blitzima may be adjusted by your healthcare professional , or you may be given other medicines ( pre - medication ) to reduce the risk
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and will generally disappear after a few days of treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / ml ). each 50 ml vials contains 500 mg of the active ingredient in ritiximab , 10 mg per ml . the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion supplied in glass vials ( 2 ml v glass vial with 50 ml ). pack size of 1 v
roactemra contains the active substance toilizumab , a type of protein called monoclonal antibody ( maoi ) that attaches to a specific target in the body called interleukin - 6 ( interlekin - 7 ). this target is designed to bind to a protein in your body that is involved in causing the inflammation in yourbody . roactemrea can help prevent symptoms such as pain and swelling in your joints . roactoremra is used to reduce the damage to the cartilage ( bone that supports the joints ) caused by the disease . roACTemra can be used
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . during the infusion with roactemnra , you may experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips and skin rash . these reactions are usually mild and go away within a few days of the infusion . infection if you get infections , tell your doctor immediately . if you feel unwell after receiving roactremra , your body ' s ability
the doctor or nurse will give you roactemra into a vein by a nurse . you will be given the intravenous infusion once a day . the treatment will be started by a doctor or a nurse and will be repeated every 8 weeks . the recommended dose is 8 mg roacterera given once a week as a drip in the vein ( intravenous infusion ). the treatment is started as follows : week 8 week 8 weeks roactemera will be administered once a month for up to 8 weeks in total . this dose is given as 4 mg once a year as a dip in the veins ( intravenously infusion ).
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in the following frequencies ( see section 3 ): stop taking roactamra and see a doctor straight away : serious side effects ( may affect up to 1 in 10 people ) allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity ( may occur
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the outer carton and on the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 ml . each 10 ml vials contains 200 mg of of tocelizumumab ( 20 mg / 20 ml ). each 20 ml vinal contains 400 mg of the active substances in tocilixumab 20 mg . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like and contents of the pack ro
what onbrez breezhaler is onbreezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it relaxes the muscles in the walls of the small air passages in the lungs . what onbrezy breez inhaler is used for onbrezer is used to make breathing easier for adult patients with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine relaxes these muscles in your lungs , making it easier for air to get in and out of
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if there are any signs of heart problems such as epilepsy . - warnings and precautions talk to your doctor or pharmacist before using onbrezer . - tell your doctor if you have : - tightness of the chest , coughing , wheezing or breathlessness immediately after using on brez breezer . these may be signs of a condition called bronchospasm .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day ( one 150 and one 300 microgram ). your doctor will tell you how many capsules to use and how long you should continue the treatment . you should use your inhaler at least 24 hours after you last inhaled it . onbrez breezhaler is supplied as an inhaler and capsules ( in blisters ) containing the medicine . the medicine is inhaled using inhalation powder . the onbreez breez inhaler contains the
what onbrez breezhaler contains - each onbrex breez inhaler 150 mg capsule contains 150 mg indacaterol ( as indacataterol maleate ). - the other ingredients are lactose and the capsule is made of gelatin . - eachonbrez bronz inhalER 300 mg capsule also contains 300 mg indiacaterol , as indaconaterolmaleate . - the ingredients are made of lactoseand the capsule contains gelatin . what onbreez breezeler looks like and contents of the pack onbrezy breezer 150mg capsules are white to off - white
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel hcs - if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). - if your medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if severe liver disease . if you think any of these apply to you , or if you have any further questions on the use of clopridogrel clcs , ask your doctor or pharmacist . warnings and precautions talk to your doctor before taking clopidineogrel hex : - if bleeding is not being controlled - if a medical condition
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopide ( as hydrochloride ). the other ingredients are ( see section 2 ' clopidaogrel hexa contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil in the tablet core ; film coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron
feciderocol is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics are antibiotics that help to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that you have not previously been able to fight with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other antibiotics ( e . g . cephalosporins ). if this applies to you , tell your doctor before using fetcroj . if you have had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ). if any of these apply to you ( or you are not sure ), tell your physician before using this medicine . if any allergic reaction occurs to any of your other antibiotics , tell
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it usually takes about 3 to 2 weeks . your doctor will decide how long fetcroja treatment will last . your dose will be decided by your doctor . your infection will be treated as soon as possible . you should not feel any pain during the fetcroJA infusion . it is recommended that you continue to receive fetcrora for as long as your doctor prescribes it for you . if you have kidney problems if you suffer from kidney problems , your doctor may decide to reduce your dose of fetcroje . if your
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . if you have this reaction , you may have diarrhoea , stools , blood or mucus . treatment may be stopped or medicines given to slow bowel movement may cause this reaction . other side effects include : common side effects ( may affect up to 1 in 10
what fetcroja contains the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefirocol . the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojas is a white to off - white powder for concentrate for solution for infusion . it is supplied in packs containing 10 vials .
depocyte is used to treat lymphomatous meningitis . lymphomatinous menenitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is prepared from lymphoma tumour cell material .
do not use depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a meningeal infection . warnings and precautions talk to your doctor or pharmacist before using depocyte . severe neurological side effects have been reported with depocyte , with symptoms suggesting an increase in the nervous system ( convulsions , pain , numbness , tingling , blindness , visual disturbances ). if you experience any of these symptoms , stop using depocytes and contact your doctor immediately . taking any dexamethasone tablets may increase the risk of
treatment of cancer in the lumber sac will be overseen by a doctor who is experienced in the use of depocyte . depocyte will be given to you by a qualified healthcare professional . the recommended dose is one vial of 1 mg or 5 mg of dexamethasone per day . the dose is 5 mg . your doctor will adjust each depocyte dose to prevent any side effects . the amount of depocytes that you will receive will depend on the temperature ( up to 22 ) and the quantity of liquid you are taking . the maximum recommended dose should not exceed 30 mg / kg . before withdrawing depocyte from the vial
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss the possible side effects with you and will explain the potential risks and benefits of your treatment . the following side effects have been reported with depocyte : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 patient in 10 , 000 ): very rare cases of adverse events have been observed with depocytes . depocyte may be administered with other chemotherapeutic agents . very common : may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . depocyte may be stored at room temperature ( up to 25 ) for up to 4 weeks . do this to protect from light . do do not return depocyte to the refrigerator . do away with this medicine if you notice severe discolouration , a changed appearance or a defective container . depocytes must be used within 4
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cytarbine . one vial of 5 ml solution contains 50 mg cytabine ( as besilate ). - the other ingredients are cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoylophosphatideglycerol , sodium chloride , water for injections . what depocyte looks like and contents of the pack depocyte is a solution for injection . it is supplied in a 5 ml glass vial as a single injection . each pack contains
what bemrist breezhaler is bemist breez inhaler contains two active substances called indacaterol and mometasone furoate . indacatersol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the lungs , making it easier for air to get in and out of the lungs . mometsone furyate belongs to the group of medications called corticosteroids and steroids . corticoposteroids reduce the swelling and irritation ( inflammation ) in the small airways in the lung , which can lead to breathing problems . cortics
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). - if any of these apply to you , tell your doctor before using bemrid breez inhaler . - if your doctor thinks you may be allergic . - warnings and precautions talk to your doctor or pharmacist before using this medicine : - if : - you have heart problems , such as an irregular or fast heartbeat - you are elderly - you suffer from thyroid gland problems - you drink alcohol excessively - you smoke
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with water . the medicine should be inhaled once a day . if your asthma does not improve or your symptoms get worse , your doctor may prescribe bemrid breez inhaler . how bemist breezhhaler is for inhalation use . be mrist breezezhalzer is supplied as an inhaler and capsules . the inhaler contains the medicine . the capsules are for inhalations only . the instructions for use are
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction ( uncommon ( may affects up to 1 in 100 people ): swelling of your tongue , the lips , face or throat ( angioedema ). other side effects other side side effects include : very rare ( may effect up to1 in 10 , 000 people ): sore
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram ( inhaled ) contains 173 microgram indacate ( asacetate ) 150 microgram of indacates ( as methotrexate ) 80 microgrammometason furoates . the mouthpiece of the inhaler contains 125 microgig indacatedol ( equivalent to 62 . 95 microgram mometsone furuate ). bemrid breez
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zyllt is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). zllt is also taken to prevent the
do not take zyllt - if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if the patient has severe liver disease . warnings and precautions talk to your doctor or pharmacist before taking zylltt if any of these apply to you : - if bleeding is not being controlled with zyllT - if a medicalcondition that puts you at risk of internal bleeding ( such as : a stomach ache
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended daily dose is one 25 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 under ' zylltic contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what zyllts
what lamivudine teva is lamivudaine tella is a medicine used to treat long term ( chronic ) hepatitis b infection in adults . lamivuxine tevas is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic " infection can lead to liver damage . lamlivudineteva helps to protect your liver by preventing the multiplication of hepatitis b and helps to prevent compensated liver disease after treatment with lam
do not take lamivudine teva - if you are allergic to lamivuda or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamividine tevas may be taken with other similar medicines which may have serious side effects . - if your doctor has told you that you have liver disease ( hepatitis c ). - if the patient is overweight . your doctor will do blood tests before you start your medication ( see section 4 " warnings and risks "). if you take lamidudine tea to treat your hepatitis , you should not take it again until your doctor tells you otherwise
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage your doctor lamivudine teva is used to treat your hepatitis b infection . your doctor will tell you how many tablets of lamivuda teva to take and when to stop your infection . it is important that you continue to take lamivodine teeva until your illness is completely gone . if you have any further questions on the use of lamvudine eteva , ask your doctor . if lamivadine tevas is used for the treatment of your kidneys , your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in clinical trials for other conditions linked to hepatitis b . the side effects that have been observed during therapy for hepatitis b are listed below . the most common side effects reported during lamivudaine clinical trials were tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea , and increases in liver enzymes . the liver may make enzymes that help to relax muscles . allergic reaction ( rare , may affect up to 1 in 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . do away with lamivudine teva once you have taken it . do this once you realise it has been taken out of your refrigerator . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment
what lamivudine teva contains - the active substance is lamivu . each film - coated tablet contains 100 mg of lamivubine . - the other ingredients are microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivUDine teeva looks like and contents of the pack orange , biconvex film - coat : 32 lamivodine
nespo is an anti - anaemic ( means that your anaemia is not caused by any other medicine ). anaemia occurs when your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . nespo works by inhibiting the natural hormone erythropoietin . erythroietin works by blocking the effects of erythromycin in your kidneys . it also prevents your bone marrow from producing red blood cell ( darbepoetin alfa ). nespos is used : to treat chronic renal failure ( symptomatic anaemia ) to treat
do not use nespo if you have high blood pressure or are taking other medicines that are allergic to nesco ( darbepoetin alfa ) or r - huepo . if you suffer from high bloodpressure and you are taking medicines to treat sickle cell anaemia . if your child has epileptic fits ( seizures ). if your newborn has convulsions or fits . if he / she has liver disease . if any of the above applies to your child , do not use drugs to treat anaemia and talk to your doctor . warnings and precautions talk to the doctor before using nespos if
your doctor will carry out blood tests before you are given nespo to check your haemoglobin level . the usual starting dose is 10 mg . your doctor will then increase your dose to a haemoglobulin level of 10 mg every 12 hours . the pre - filled syringe is for injection into a vein . if you have chronic renal failure , your doctor may give you a single injection under the skin into a veins ( intravenous ). the dose will be adjusted by your doctor depending on how your anaemia is responding to nespos . the dose given will depend on your body weight . the recommended dose is 0
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : 471 common ( may affect up to 10 in 100 people ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( may effect up to 1 in 100 , 000 people ): blood clots ( thrombosis ) pain in the area injected rash , redness and / or the skin rare ( may affects up to one in 10 , 000 , 000 patients ): serious allergic reactions sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep your syringe in the original package in order to protect from light . after first opening of your syringes , you may store nespos at room temperature ( up to 30 ) for a maximum of 7 days . do this at the end of this period . do away with nespen after this period and return
what nespo contains - the active substance is darbepoetin alfa . each ml of a pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu of the active substances darbasetin aluminium and nespos contains sodium phosphate monobasic , sodium phosphate dibasic ( e1200 ), sodium chloride , polysorbate 80 and water for injections . what nesco looks like and contents of the pack nespi is a clear , colourless to slightly pear
macugen is a solution for the eye called pegaptanib . this medicine works by stopping abnormal formation of new blood vessels in the eye . macugen is used for the treatment of macular degeneration in adults . in this disease , vision loss is caused by damage to a part of the retina called the macula . macula is the thin layer at the back of the eye ( the macular ) that surrounds the eye , the macul . macular is the layer that lines the front part of your eye . amd means that abnormal blood vessels grow in the retina and become larger than normal . macug widens these
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in or around the eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you have or have ever had an infection , including bleeding in the eye , before or after macugen injection . tell your doctor immediately if you experience any of any of these following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , small particles in your vision . these
how much macugen is given and how often it is given the doctor will decide how much macug is needed . macugen will be given to you by a doctor or nurse . a single injection into your eye will be administered every 6 to 9 weeks . the injection will be injected into the vitreous ( the coloured part of the eye ). the doctor or healthcare professional will clean your eye with some local anaesthetic (umbing medicine ) to prevent any pain where the injection is given . if you are allergic to antibiotic eye drops , you will be monitored closely for signs of antibiotic treatment . if any of the above apply to you (
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms may include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported during macugen treatment . the symptoms are described in section 2 . if you experience any of these symptoms , contact your doctor immediately . other side effects very
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the medicine in the original package in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml solution . - the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ), water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains a pre -filled syringe of 0 .
palifermin belongs to a group of medicines called escherichia coli . palifermin works by blocking the growth of epithelial cells in the mouth and digestive tract and in the tissues below the skin . palififermin is used to treat oral mucositis ( soreness , dryness , inflammation of the mouth ) as an additional side effect that may be considered when you are receiving treatments for your blood cancer . if your bloodcancer is not well controlled with chemotherapy , radiotherapy or autologoushematopoietic stem cell transplantation ( a procedure that can transplant blood cells ) it may be more likely that
do not use kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents kepvelance is not recommended for use in children and teenagers under 18 years of age . other medicines and kepervance tell your doctor or pharmacist if you have recently taken or might take any other medicines . this is because kepivalance may interact with heparin . if you recently taken heparan , tell your
before starting cancer treatment , your doctor will decide how much kepivance you should receive . the recommended dose is 60 mg . your doctor or nurse will give you kepvelance in a single dose of one kilogram ( kg ) as an intravenous injection into a vein . you will be given kepvance once a day for three days . chemotherapy ( radiotherapy ) chemotherapy and radiotherapy are given every three weeks as chemotherapy and radiationotherapy . radiotherapy is given every 24 to 48 hours during the chemotherapy and after radiotherapy . you may be given radiotherapy once a week for up to three days after the chemotherapy
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth and tongue , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , decrease in lipase and amylase levels in the blood , and increased levels of digestive enzymes in the bloodstream . the frequency
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepivismance looks like and contents of the pack kepvelance is a white powder supplied in a vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitet , which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . cinocalcate accordphara is used in adults to treat secondary hyperparathyroidism ( secondary ) when they have serious kidney disease or are not benefiting from dialysis because they are not able to eliminate the excess of calcium in the bloodstream ( hypercalcaemia ). parathyrot
do not take cinacalcet accordpharma - if you are allergic to cinacealcep or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will check your blood calcium levels regularly while you are taking cinocalcot accordphara . warnings and precautions talk to your doctor or pharmacist before taking cicalcut accordpha : - if any of these apply to you , tell your doctor before taking this medicine . - if your doctor has told you that you have a history of seizures
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma should be taken orally with or without food . you should take cinocalcate accordpharmat once a day for at least one hour . the tablets should be swallowed whole with some water . your doctor will take regular blood samples during treatment to monitor the progress of secondary hyperparathyroidism . the usual starting dose of cinicacalcitpharma is 30 mg once a morning . your
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches or cramps , seizures , as these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth , tongue or throat , which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects seek medical advice immediately . common ( might affect up to 1 in
what cinacalcet accordpharma contains - the active substance is cinocalcep . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinicet ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinacealcelcet accordpharma looks like and contents of the pack cin
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformined belongs to the class of substances called biguanides . they work together to lower blood sugar levels in adult patients with diabetes called ' type 2 diabetes mellitus '. this medicine works by helping your body make better use of insulin . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or empagliflozin
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severely reduced kidney function . - if any of these apply to you , tell your doctor before taking jentadoeto . warnings and precautions talk to your doctor or pharmacist before taking this medicine : - if the patient has severely reduced liver function . if the person has uncontrolled diabetes ( with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should be taken with or without food . if you currently take metformin ( as individual tablets ), your doctor may prescribe linagliptin or metformatin together with food . always take this medication exactly as described in this leaflet or as your pharmacist has told your doctor . if this medicine is not suitable for you , you may experience an upset stomach . the recommended dose is one 5 mg linaglptin tablet once a day , with or with food , and 2
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change and confusion . hypoglycemia is a very rare ( may affect up to 1 in 10 , 000 people ) side effect , but can be life threatening . jentodueto plus sulphonylurea may be combined with the combination jentadenu
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the blister in the original package in order to protect from light . do this medicine if you notice any visible signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metforma hydrochlorides . - each jentinueto 1 , 000 mg film film - coating contains 2. 5 mg linagoptin and 1 , 500 mg metin hydroxychloride ). - the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hyp
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older who are already taking hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants works by reducing the amount of hiv in your body . it is used in combination with hiv medicine in adults and adolescents aged 12 months and older , who are infected with h hiv . edaurant is not a cure for hiv unless you have been taking h hiva
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurent if you : are taking any of any of : the following medicines : carbamazepine , oxcarbazepine ( e . g . phenobarbital and phenytoin ) medicines to treat some bacterial infections ( e. g . tuberculosis ) omeprazole , esomeprazole ( e1201 ), lansoprazole or pantoprazoles , rab
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( from 18 years of age ) the recommended dose of edurant is 1 tablet once a day . do not take more than one tablet once daily . do this if your doctor tells you to . do the following : - take rifabutin ( a medicine used to treat some bacterial infections ). edurants can be taken with or without food . - do not crush , chew or break the tablet . - take edurent with food . do these things as instructed by your
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , or changes in your routine liver tests ( transaminase ) increase in cholesterol and pancreatic amylase in your blood abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your body ( triglycerides , lipase , bilirubin
what edurant contains the active substance is rilpivirine . each tablet contains rilpalpivira hydrochloride . each film - coated tablet of edurants contains rrilpivire hydrochlorides equivalent to 25 mg rilpaivirrine . the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . the film - coating : lactate monohydrate ( see section 2 ), hypromellose 2910
avandamet tablets are two different medicines , rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . type 2abetes occurs when your body does not make enough insulin to control the level of sugar in the blood . your body also does not produce enough insulin when you are taking rosigllitazONE and met formin . this helps your body make better use of the insulin it produces . your doctor will check whether avandamter is working as well as it should if it has been given to you as a sulphonylurea ( a type of
follow all your doctor ' s instructions carefully . check with your doctor or pharmacist if you are not sure . your doctor will decide what dose is best for you and will also tell you what other medicines you need to take to control your diabetes . do not take avandamet if any of the above apply to you . if you have not been treated with avandamanet before , talk to your doctor , pharmacist or nurse before taking avandandamot : if you : have had a heart attack or severe angina have heart failure have had heart failure in the past have severe breathing difficulties have liver disease have diabetic
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is taken once a day , with or without food . this dose may be taken with or just after meals . the maximum dose is 4 mg rosciglitizone ( corresponding to 1000mg metforma ). thisdose is taken with food . the recommended dose is also 2 mg avandamanet ( equivalent of 300 mg ). swallow the tablets
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet may include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), with difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamot and seek medical advice straight away . lactic acidosis ( build up of lactic acids in the blood ( lacticacidosis is a common side effect in patients taking metformin ) and seek urgent medical advice from a doctor . severe kidney disease can cause symptoms of l
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this to avoid spoilage . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths . each tablet contains 1 mg rosigllitazon , 500 mg metforma , 2 mg rosciglitasone , 500mg metforman , 2mg rosigslitazione , 1000 mg met formin . each 4 mg tablet contains rosigglitazion , 1000mg met formformin ). the other ingredients are sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose monohydrate , p
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrelmylan is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel mylan 31 if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you ( or you are in any doubt at all ), consult your doctor before taking clopridogrelmylan . warnings and precautions talk to your doctor or pharmacist before takingclopidoggingrel myl
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopidiogrelmylan contains hydrogenatedcastor oil '), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogl 3000
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thrombolocytopenia ). it is used in adults , adolescents and children as a medical procedure to reduce the risk of bleeding . it works by reducing the number of platelets . platelets are blood cells that are needed in the blood to clot and prevent bleeding .
do not use doptelet if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using doptelelet if : you have ever had blood clots in the veins or arteries ( which may increase the risk of blood cl clots ) you have had bloodclots in cancer you are taking the contraceptive birth control pill or hormone replacement therapy you have recently had surgery or are seriously injured 23 you are overweight or have advanced chronic liver disease you are not sure if any of these apply to you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet once a day , taken at least 8 hours apart . your doctor will tell you the dose of doptelet to take . the dose may be adjusted by your doctor if necessary . the recommended dose of the dose for adults is 20 mg , 40 mg or 60 mg once a week , taken in the morning and evening , taken approximately 5 hours apart , taken once a morning , and once in the evening , at approximately the same time each day . your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain swelling bone pain muscle aches fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet .
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormboprag maleate equivalent to 20 mg avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 under ' doptelets contains lactose '), microcrystalline cellulose , crospovidone type b [ e ], silica , colloidal anhydrous , magnesium stearate . - film - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ).
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these are used to monitor the heart arteries and to measure heart rate and the muscles in the heart . rapiscan is used in adults to obtain a type of heart scan called ' myocardial perfusion imaging '. the scan contains a radioactive substance called a ' radiopharmaceutical '. these images are taken using a type - i camera called ' magnetic resonance imaging '. these pictures are taken onto the muscles of the heart using a readmill . a scan is only possible if you have a small amount of radiopharma ( radioactivity )
do not take rapiscan if you have slow heart rate , high degree heart block , sinus node disease , or a pacemaker that does not work properly . if you get chest pain ( unstable angina ) during treatment , low blood pressure ( hypotension ) or heart failure . if your doctor thinks that you may be allergic to regadenoson or any of the other ingredients of rapiscin ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking rapiscen if any of these apply to you : if you are not sure , talk to a doctor or go to a hospital straight
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) over a period of 400 minutes . the recommended dose is a 5 ml solution the injection will be administered over a minimum of 5 to 10 minutes depending on your weight . the dose may be administered with an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution or with 5 ml ( 1 %) water for injections . if you are given a radioactive substance ( radiopharmaceutical ), the dose of rapiscan may be adjusted
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects usually occur within a few days of the rapiscin injection and usually disappear within 30 days without any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be signs of damage to the heart called heart block , a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face and inability to speak . rapiscans may cause a stroke ( cerebrovascular accident ) or an
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viagagra is a treatment for adult men with erectile dysfunction ( impotence ). this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed medicines containing nitrates which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). if you have not been prescribed any of these medicines , consult your doctor . - if the doctor has recently prescribed nitric oxide donors such as amyl nitrite which could also lead to an increase in your risk of a dangerous drop in yourblood pressure . - when taking ri
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg . viagra film - coated tablets are for oral use only . viaga orodispersible tablets are also for oral . swallow the tablets whole with a glass of water . viagagra can be taken with or without food . viampicin may also be taken as an erection if you get sexually stimulated . if you take more viagra than you should if you accidentally take too many tablets , contact your doctor immediately . if possible take viagra with food . swallow
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with viagra are usually mild to moderate . if you experience any of the following side effects stop taking viagra and seek medical help immediately : an allergic reaction ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing , dizziness , swelling of the eyelids , face , lips or throat . chest pains may be more common if you are in a semi - sitting position . you should use nitrates to relieve your chest pain . prolonged and sometimes painful erections ( may occur rarely ,
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are engraved with the
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : - treat the symptoms of primary parkinson ' s disease in adults ; - alone or in combination with levodopa . in adults with parkinson ', sifroll is used : - to treat thesymptoms of moderate to severe primary restless legs syndrome in adults .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sifol if you have any medical conditions or symptoms that could be associated with kidney disease such as hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . dyskinesia ( abnormal , uncontrolled movements of the limbs ) is a common symptom of advanced parkinson ' s disease . if you take levodopa for dyskineia , you should not take more sifroll than your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets per day . the first week of the first treatment : 1 tablet of sufrol 0 . 088 mg each day ( equivalent to 0 . 264 mg ). 1 tablet in the second week of treatment : 2 tablet of the sifol 0 .088 mg each morning ( equivalent of 0 . 270 mg ). if your symptoms return after 1 week , your doctor may increase your dose to a maximum of 1 tablet . 2 tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common : may affect more than 1 in 10 people common : might affect up to 1 in 100 people uncommon : may affects up to1 in 1 , 000 people rare : may effect up to one in 10 , 000 patients not known : frequency cannot be estimated from the available data - parkinson ' s disease the following side effects have been reported with sifrol : - dyskinesia ( abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) -
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg of pramipxole ( as 0 . 125 mg , as 0. 25 mg , and as 0 as 1 mg pramidexole dihydrochloride monohydrate ). the other ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what sifroll looks like and contents of the pack sifol 0 .088 mg tablets are white to off
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye in adults . it is used to prevent allergic conditions from occurring in the eye . the allergic reaction to allergic conjutivitis may be caused by exposure to some materials ( allergens ) that may cause allergic reactions such as itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor immediately . do not change your daily dose or contact your doctor if you feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 months old . warnings and precautions talk to your doctor or pharmacist before using emadin : - if the active substance in emadadine is benzalkonium chloride . this is because emadrine contains less than 6 mg benzalkin . clinical trials have shown that the effect of emadmine on kidney or liver problems has not been studied . children and adolescents do not give this medicine to children or adolescents under the age
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use adults use one drop twice a day ( 1 drop in the eye ) for one hour . use this bottle once a day in the morning and once in the evening . do not use this in the eyes . children and adolescents use in children and teenagers use in adults and adolescents below the age of 3 years . the recommended dose is 1 drop twice daily ( 1 dose in the mornings and 2 drops in the night ). children and adolescent use in adolescents use 1 drop once daily in the same eye
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be used immediately after application . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects these may affect upto 1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneel staining and dry eye . general side effects : headache , difficulty sleeping , sinus headache , bad taste , rash . general
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from infections . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emadine contains - the active substance is emadastine 0 . 5 mg / ml . - the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide to maintain acidity levels and ph levels . what emadrine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetir acetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). levantiracetaman is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ). leveiracetamer has been given to you by your doctor to reduce
do not take levetiracetam actavis - if you are allergic to leveturacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking levetvetir acetam activ - if your child has kidney problems - if he / she has any slow down in the growth or unexpected puberty development of your child . anti - epileptics should be used in children and adolescents . levetiraacetam actsavis should not be used if your infant has thoughts of harming or killing themselves . if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . levetiracetam actavis is taken as an injection in the morning and in the evening . monotherapy dose in adults and adolescents from 16 years of age and older : the usual dose is 1 , 000 mg once a day . the dose may later be increased to 3 , 000mg once a daily . your doctor will tell you the dose to take . when to take levetvetir acetam acta in combination with food and drink the usual starting dose is 2 tablets once a morning . this
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms and a rash on the face followed by an extended rash with a high temperature and increased levels of liver enzymes seen in blood tests ( a type of white blood cell ) 56 in patients with eosinoph
what levetiracetam actavis contains the active substance is levetviracetam . levetiraacetamactavis 250 mg : each tablet contains 250 mg of levetvetir acetam . each tablet of leveriracetaman actavis 500 mg : one tablet contains 500 mg of the active ingredient levetmiracetam. levetiroacetam Actavis 750 mg : every tablet contains 750 mg of strength levetirusacetam ( as levetroacetam ). levetiralacetam effectavis 1 , 000 mg : the active substances are : tablet core : crospovidon , p
incruse ellipta contains the active substance umeclidinium bromide , which belongs to a class of bronchodilators . incruseipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways and airways in the lungs become damaged and not able to use effectively . this can lead to breathing difficulties . difficulties in breathing can also result in tightening of the muscles around the airway . this medicine works by tightening these muscles in the air passages in the lung , helping to control your breathing difficulties and reducing the
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : - if your child has asthma . incruruse ellipta should not be used in children with asthma . - if the child has heart problems . - tell your doctor if your baby has an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). - if he / she has severe liver
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . do not use more than your doctor tells you to use . if you use more incruse ellipta than you should if you have used more inculse elliptas than you have been told to use , contact your doctor immediately . symptoms of using too much of this medicine may include a sudden attack of breathlessness or wheezing . if this attack occurs , contact
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash ( hives ) redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination ( signs of a urinary tract infection ) common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead ( signs may indicate inflammation of the sinuses called
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the inhalcer in the sealed tray in order to protect from light . after first opening of the tray , the inhalER should be used within 6 months . once the tray has been opened , the active substance should be removed from the tray and used immediately . do this if the inhalizer has been accidentally
what incruse ellipta contains - the active substance is umeclidinium bromide . each delivered dose contains 55 micrograms umebolidinia ( equivalent to 65 microgram ) umecylidinIUM bromides . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate . what incrute ellipta looks like and contents of the pack incrupe ellipta is an inhalation powder . the ellipta inhaler is supplied in a grey plastic body with a light green mouthpiece cover
what nucala is nucal contains the active substance mepolizumab , which is a monoclonal antibody . this type of protein is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type of white blood cell that helps the lungs to work ) in adults . eosynophilic asthma is the most common form of asthma nucalan is used in adults to prevent asthma attacks when you are taking medicines called high dose inhalers . it helps control your asthma when you take these medicines . it is also used in
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 patients have experienced asthma - related side effects during treatment with nucal . if your asthma is not controlled with nocala , your doctor may decide to temporarily stop nucale treatment . if you think you may be allergic , ask your doctor for advice . injection site reactions medicines of this type ( monoclonal antibodies ) cause severe allergic reactions to other parts of your
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg once a day . children and adolescents 1 year of age or older : your doctor will decide the dose you should receive . the pre - filled pen will be used to inject nucala . duration of treatment your doctor may decide to continue to give nucal if you are not able to tolerate the treatment . if you miss a dose of nucale , do not stop the treatment without talking to your doctor first . if your asthma symptoms return or attacks do not improve , your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ). they may occur within a few hours of the injection . sometimes symptoms can be severe and include symptoms such as chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction similar reaction to a similar reaction
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the pen label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the nucal pre - filled pen in the outer carton in order to protect from light . after first opening , the pen may be stored for up to 7 days in the refrigerator ( 4 8 ). discard the pre - used pen after 7 days . do away with the pre pre - fill pen if it is discoloured or
what nucala contains - the active substance is mepolizumab . each 1 ml ampoule contains 100 mg of mepolixumab - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucalan is supplied as a 1 ml clear glass ampoules , packaged in a pack containing 1 ampouled or a multipack containing 3 ampouls , each containing 1 vial .
what ninlaro is and how it works ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib works by stopping cell survival and slowing down the number of myelomas cells . it works by blocking a lot of proteins called proteasomes . what is the purpose of ninlaron ? what is multiple myelo ? how does it work ? in multiple myelinoma , the active ingredient in ninlao is
do not take ninlaro - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar : - if any of these apply to you , tell your doctor before taking this medicine . warnings and symptoms talk to the doctor or nurse before taking any of this : - before taking the first dose of ninlero , if you experience bleeding , persistent nausea , vomiting , diarrhoea , nerve problems , tingling , numbness , swelling or a persistent rash . - if your doctor determines
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of ninlaro for multiple myeloma is one capsule a day . you should take this capsule at the same time each day . your doctor will tell you how many capsules of ninlio to take . if you cannot take lenalidomide or dexamethasone , you should continue taking the capsules for 4 - week . if your doctor tells you to take one capsule of ninlonaro once a day , on the same day of the week . for the first 3 weeks ,
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds or easily bruising nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash ( itchy , often on the entire body ). rare side effects may affect up to 1 in 1 , 000 people : severe skin rashes , red to purple bumps ( sweet '
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from moisture . once the capsule has been opened , use this medicinal product immediately . do this medicine only if you notice any damage or signs of tampering to medicine packaging . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains - the active substance of ninlar is ixazomib . each capsule contains 2 . 3 mg ixasomib and 3 . 3mg ixabomib citrate . - the other ingredients are microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide [ e172 ]. - the printing ink contains : - the capsule content contains : ixar 3 mg / ixa (
palforzia is used to treat adults allergic to peanuts ( arachis hypogaea ). palforza is used in children and adolescents from 4 to 17 years of age for treatment of peanut allergy caused by peanut ( desensitisation ). pafforzias does not cause allergic reactions . palfORzia has been shown to reduce the risk of food allergies . if you have any questions about how palforbzia works or why this medicine has been prescribed for you , ask your doctor .
do not take palforzia - if you are allergic to peanut or soya - if your asthma is getting worse - if there is a problem swallowing - if this is the case - if it is the first time you have had long term problems with your digestive system - if the first dose has been missed - if any of the above applies to you - if a severe mast cell disorder ( e . g . severe or life - threatening anaphylaxis ) has occurred within 60 days of stopping treatment with palfORzia . warnings and precautions talk to your doctor or pharmacist before taking palfnorzia
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose is one tablet once a day . allergy if you experience allergic reactions ( anaphylaxis ) within 3 months of starting treatment with palforzia , your doctor may prescribe additional doses for initial doseescalation . these treatment steps are described below . the initial dose escalation and up - dosing steps are given below . if you take more palfdorzia than you should if you have accidentally taken too many tablets , contact your doctor immediately . if possible , show the doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : severe allergic reactions : if you have any of the following symptoms while taking palforfzia , stop taking the medicine and seek medical help immediately : trouble breathing , throat tightness , feeling offulness , trouble swallowing or speaking - changes in voice , dizziness or fainting severe stomach cramps , pain , vomiting , diarrhoea , severe flushing and itching of the skin palfORzia may cause problems with the stomach and digestive system ( eosin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or if the solution is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palfoforz . each 0 . 5 mg capsule contains 1 , 10 or 20 mg oral powder in capsules . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palforbzia 100 mg oralpowder in capsules with opening microcrycrystallrine cellulose ( e460 ), colloidal Anhydroussilica and and magnesium strearate pregelatinised palfborzia 300 mg oral solution in sachet microcrystine celluloses ( e464 ), colloid anhydrated
zerne belongs to a group of substances called benzodiazepine - related medicinal products . it contains hypnotic actions . it is used to treat sleeping problems in adults who are not fully responsive to treatment . it should be used only when you are fully responsive , and not when you have been fully responsive . your doctor will check whether treatment is having the desired effect and will tell you if you have problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( very weak , tired muscles , severe breathing , chest problems ) if any of these apply to you , tell your doctor . children and adolescents zeren is not recommended for use in children and teenagers under 18 years of age . therefore , zerenes has not been studied in this age group . undesirable
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg capsule once a day . if you have difficulty falling asleep , you should take the capsule at bedtime . adults 65 years of age and older with mild to moderate liver problems the recommended starting dose is two 5 mg capsules once a night . if your doctor determines that you have mild tomoderate liver problems , the recommended recommended starting dosage is one 5 mg capsule twice a day , taken at bedside . the capsule may be cloudy or coloured . if this happens , you may
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 5 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ). very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) very rare : very rare , affects less
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate . - capsule shell : lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( i171 ). - printing ink : gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (> e172 ) and sodium laurel sulphATE ( e 171 ), silicon dioxide , ( e 132 ). printing ink: shellac
